Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
95000,95000,,,2303290,[],CHEMBL1000544,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after 14 passages by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
95001,95001,,,2303295,[],CHEMBL1001460,Antimicrobial activity against methicillin and vancomycin-resistant Staphylococcus aureus 510 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95002,95002,,,2304375,[],CHEMBL1001461,Antimicrobial activity against methicillin and vancomycin-resistant Staphylococcus aureus 509 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95003,95003,,,2304376,[],CHEMBL1004900,Antimicrobial activity against methicillin-resistant vancomycin-intermediate Staphylococcus aureus 555 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95004,95004,,,2304377,[],CHEMBL1004901,Antimicrobial activity against methicillin-resistant vancomycin-intermediate Staphylococcus aureus 504 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95005,95005,,,2304378,[],CHEMBL1004902,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 481 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95006,95006,,,2304379,[],CHEMBL1004903,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 490 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95007,95007,,,2304380,[],CHEMBL1004904,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 525 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95008,95008,,,2304381,[],CHEMBL1004905,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 547 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95009,95009,,,2304382,[],CHEMBL1004906,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 540 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95010,95010,,,2304383,[],CHEMBL1004907,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 543 after single-step resistance selection by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95011,95011,,,2304418,[],CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95012,95012,,,2304424,[],CHEMBL999689,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus by agar dilution CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95013,95013,,,2304430,[],CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
95014,95014,,,2304436,[],CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95015,95015,,,2304442,[],CHEMBL999690,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1137665,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783677,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95016,95016,,,2353275,[],CHEMBL966106,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95017,95017,,,2353276,[],CHEMBL966106,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95018,95018,,,2353291,[],CHEMBL966107,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95019,95019,,,2353292,[],CHEMBL966107,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95020,95020,,,2353307,[],CHEMBL966108,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95021,95021,,,2353308,[],CHEMBL966108,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,4.0
95022,95022,,,2353323,[],CHEMBL966109,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95023,95023,,,2353324,[],CHEMBL966109,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,8.0
95024,95024,,Active,2353339,[],CHEMBL965279,Antibacterial activity against Streptococcus by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,,,,
95025,95025,,Active,2353340,[],CHEMBL965280,Antibacterial activity against Enterococcus by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,Activity,,,,
95026,95026,,Active,2353341,[],CHEMBL965281,Antibacterial activity against Moraxella catarrhalis by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,,,,
95027,95027,,Active,2353342,[],CHEMBL965282,Antibacterial activity against Listeria monocytogenes by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,Activity,,,,
95028,95028,,Active,2353343,[],CHEMBL965284,Antibacterial activity against Nocardia sp. by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL612979,Nocardia sp.,Nocardia sp.,1821.0,,,Activity,,,,
95029,95029,,Active,2353344,[],CHEMBL965285,Antibacterial activity against nontuberculous mycobacteria by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,,Activity,,,,
95030,95030,,Active,2353345,[],CHEMBL965286,Antibacterial activity against sEscherichia coli by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
95031,95031,,Active,2353346,[],CHEMBL965287,Antibacterial activity against Klebsiella pneumoniae by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
95032,95032,,Active,2353347,[],CHEMBL965288,Antibacterial activity against sEnterobacter cloacae by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,,,,
95033,95033,,Active,2353348,[],CHEMBL965289,Antibacterial activity against Citrobacter freundii by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,,,,
95034,95034,,Active,2353349,[],CHEMBL965290,Antibacterial activity against Serratia marcescens by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,,,,
95035,95035,,Active,2353350,[],CHEMBL965291,Antibacterial activity against Morganella morganii by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,,,,
95036,95036,,Active,2353351,[],CHEMBL965292,Antibacterial activity against sAcinetobacter baumannii by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
95037,95037,,Active,2353352,[],CHEMBL966099,Antibacterial activity against sPseudomonas aeruginosa by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
95038,95038,,Active,2353353,[],CHEMBL966100,Antibacterial activity against Aeromonas sp. by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL612620,Aeromonas sp.,Aeromonas sp.,647.0,,,Activity,,,,
95039,95039,,Active,2353354,[],CHEMBL966101,Antibacterial activity against Vibrio sp. by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL613175,Vibrio sp.,Vibrio sp.,678.0,,,Activity,,,,
95040,95040,,Active,2353355,[],CHEMBL966102,Antibacterial activity against sHaemophilus influenzae by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
95041,95041,,Active,2353356,[],CHEMBL966103,Antibacterial activity against Campylobacter fetus by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL613925,Campylobacter fetus,Campylobacter fetus,196.0,,,Activity,,,,
95042,95042,,Active,2353357,[],CHEMBL966104,Antibacterial activity against Helicobacter pylori by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,,,,
95043,95043,,Active,2353358,[],CHEMBL966105,Antibacterial activity against Neisseria gonorrhoeae by CLSI dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,793423,,1,0,,,Activity,,,,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,Activity,,,,
95044,95044,,,2353359,[],CHEMBL965283,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus hominis by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,4.0
95045,95045,,,2353360,[],CHEMBL966111,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
95046,95046,,,2353361,[],CHEMBL966110,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,2.0
95047,95047,,,2353362,[],CHEMBL966112,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus saprophyticus by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,8.0
95048,95048,,,2353363,[],CHEMBL966113,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC,ug ml-1,UO_0000274,,4.0
95049,95049,,,2353364,[],CHEMBL954851,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC,ug ml-1,UO_0000274,,4.0
95050,95050,,,2353365,[],CHEMBL954852,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,2.0
95051,95051,,,2353366,[],CHEMBL954853,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,4.0
95052,95052,,,2353367,[],CHEMBL954854,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis by CLSI dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793423,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
95053,95053,,,14762635,[],CHEMBL3301363,"ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL3301361,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,,2130869,,27,1,,,LogD7.4,,,2.78,CHEMBL2362975,,No relevant target,,,,LogD7.4,,,,2.78
95054,95054,,,14764254,[],CHEMBL3301365,"ASTRAZENECA: % bound to plasma by equilibrium dialysis. Compound is incubated with whole human plasma  at 37C for >5hrs.  Method described in B. Testa et al (Eds.), Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and Computational Strategies, Wiley-VCH, Weinheim, 2006, pp.119-141. Experimental range 10% to 99.95% bound.",A,,,BAO_0000179,BAO_0000366,cell-free format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL3301361,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://qudt.org/vocab/unit#Percent,2130869,,27,1,,,PPB,%,,95.01,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,95.01
95055,95055,,,18831613,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4303101,,2020.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://qudt.org/vocab/unit#Percent,3138111,=,52,1,=,,Inhibition,%,,41.6,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,41.6
95056,95056,,,19961872,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20ÂµM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4495564,,2020.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://qudt.org/vocab/unit#Percent,3348290,=,52,1,=,,Inhibition,%,,30.41,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,30.41456025
95057,95057,,,20147896,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4495565,,2020.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://qudt.org/vocab/unit#Percent,3366162,=,52,1,=,,Inhibition,%,,-0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.15
95058,95058,,Median N= 2; Maxinhib 6.8 Pct,20239742,[],CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,MIC,nM,,20000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,uM,UO_0000065,,20.0
95059,95059,,Median N= 2; Maxinhib 7.1 Pct,20239743,[],CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,MIC,nM,,20000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,uM,UO_0000065,,20.0
95060,95060,,Median N= 2; Maxinhib 2.9 Pct,20239744,[],CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,MIC,nM,,20000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,20.0
95061,95061,,Median N= 2; Maxinhib 22.5 Pct,20239745,[],CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,MIC,nM,,20000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,20.0
95062,95062,,Median N= 2; Maxinhib 21.2 Pct,20239746,[],CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,MIC,nM,,20000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,20.0
95063,95063,,Median N= 2; Maxinhib 26.0 Pct,20239747,[],CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,MIC,nM,,20000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,20.0
95064,95064,,Median N= 2; Maxinhib 21.3 Pct,20239748,[],CHEMBL4296802,"Antibacterial activity against Pseudomonas aeruginosa PAO397 [PAO1 d(mexAB-oprM) d(mexCD-oprJ) d(mexEF-oprN) d(mexJKL) d(mexXY) d(opmH)] (CO-ADD:GN_211); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,MIC,nM,,20000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,20.0
95065,95065,,Median N= 2; Range 1.25 - 0.625  Um,20239749,[],CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,=,40,1,=,,MIC,nM,,625.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.625
95066,95066,,Median N= 2; Maxinhib 13.9 Pct,20239750,[],CHEMBL4296784,"Haemolysis of human Red Blood Cells (CO-ADD:HA_150); HC10, by OD(450)",F,,,BAO_0000179,BAO_0000219,cell-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Micromolar,3391195,>,40,0,>,,HC10,uM,,20.0,CHEMBL4296518,,Erythrocyte,,,,HC10,uM,UO_0000064,,20.0
95067,95067,,Median N= 2; Maxinhib 22.1 Pct,20239751,[],CHEMBL4296191,"Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590)",F,,,BAO_0000187,BAO_0000219,cell-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4513161,,,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3391195,>,40,1,>,,CC50,nM,,20000.0,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,CC50,uM,UO_0000065,,20.0
95068,95068,,,22077652,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4495565,,2020.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://qudt.org/vocab/unit#Percent,3366162,=,52,1,=,,Inhibition,%,,-0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.15
95069,95069,,No. Measurements = 1,22084350,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4651402,,2021.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3494117,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
95070,95070,,No. Measurements = 1,22084351,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4651402,,2021.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/Nanomolar,3494117,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
95071,95071,,,23131609,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4808148,,2021.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://qudt.org/vocab/unit#Percent,3594443,=,59,1,=,,Inhibition,%,,-7.53,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-7.53
95072,95072,,,23140280,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL4808148,,2021.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://qudt.org/vocab/unit#Percent,3594443,=,59,1,=,,Inhibition,%,,11.8,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,11.8
95073,95073,,,24994785,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5231343,Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33592 assessed as bacterial growth inhibition measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL5230110,Eur J Med Chem,2020.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3908889,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95074,95074,,,24994804,[],CHEMBL5231346,Antibacterial activity against Methicillin-resistant Staphylococcus aureus N315 assessed as reduction in bacterial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O,,,CHEMBL5230110,Eur J Med Chem,2020.0,,CHEMBL488937,CG-400549,CHEMBL488937,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3908889,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95075,95075,,,2310017,[],CHEMBL969561,Phytotoxicity against Lamb's quarters assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,5.0,CHEMBL613938,Chenopodium album,Chenopodium album,3559.0,,,Activity,mm2,,,5.0
95076,95076,,,2310018,[],CHEMBL969560,Phytotoxicity against Prickly sida assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,13.0,CHEMBL613283,Sida spinosa,Sida spinosa,108380.0,,,Activity,mm2,,,13.0
95077,95077,,,2310019,[],CHEMBL969559,Phytotoxicity against Sicklepod assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,4.0,CHEMBL613048,Senna obtusifolia,Senna obtusifolia,346985.0,,,Activity,mm2,,,4.0
95078,95078,,,2310020,[],CHEMBL969558,Phytotoxicity against Ipomoea sp. assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,8.0,CHEMBL613206,Ipomoea,Ipomoea,4119.0,,,Activity,mm2,,,8.0
95079,95079,,,2310021,[],CHEMBL969557,Phytotoxicity against Johnson grass assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,15.0,CHEMBL612631,Sorghum halepense,Sorghum halepense,4560.0,,,Activity,mm2,,,15.0
95080,95080,,,2310022,[],CHEMBL956195,Phytotoxicity against Sorghum bicolor assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,23.0,CHEMBL613055,Sorghum bicolor,Sorghum bicolor,4558.0,,,Activity,mm2,,,23.0
95081,95081,,,2310023,[],CHEMBL956194,Phytotoxicity against bent grass assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,9.0,CHEMBL613789,Poa nemoralis,Poa nemoralis,29659.0,,,Activity,mm2,,,9.0
95082,95082,,,2310024,[],CHEMBL956193,Phytotoxicity against rag weed assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,18.0,CHEMBL613801,Ambrosia artemisiifolia,Ambrosia artemisiifolia,4212.0,,,Activity,mm2,,,18.0
95083,95083,,,2310025,[],CHEMBL956192,Phytotoxicity against Nasturtium officinale assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,7.0,CHEMBL613228,Nasturtium officinale,Nasturtium officinale,65948.0,,,Activity,mm2,,,7.0
95084,95084,,,2310026,[],CHEMBL969562,Phytotoxicity against Jimsonweed assessed as leaf necrotic area at 100 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,3.0,CHEMBL613964,Datura stramonium,Datura stramonium,4076.0,,,Activity,mm2,,,3.0
95085,95085,,,2310027,[],CHEMBL969563,Phytotoxicity against Lamb's quarters assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,4.0,CHEMBL613938,Chenopodium album,Chenopodium album,3559.0,,,Activity,mm2,,,4.0
95086,95086,,,2310028,[],CHEMBL969564,Phytotoxicity against Prickly sida assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,7.0,CHEMBL613283,Sida spinosa,Sida spinosa,108380.0,,,Activity,mm2,,,7.0
95087,95087,,,2310029,[],CHEMBL969565,Phytotoxicity against Sicklepod assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,3.0,CHEMBL613048,Senna obtusifolia,Senna obtusifolia,346985.0,,,Activity,mm2,,,3.0
95088,95088,,,2310030,[],CHEMBL969566,Phytotoxicity against Ipomoea sp. assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,5.0,CHEMBL613206,Ipomoea,Ipomoea,4119.0,,,Activity,mm2,,,5.0
95089,95089,,,2310031,[],CHEMBL969567,Phytotoxicity against Johnson grass assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,11.0,CHEMBL612631,Sorghum halepense,Sorghum halepense,4560.0,,,Activity,mm2,,,11.0
95090,95090,,,2310032,[],CHEMBL969568,Phytotoxicity against Sorghum bicolor assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,18.0,CHEMBL613055,Sorghum bicolor,Sorghum bicolor,4558.0,,,Activity,mm2,,,18.0
95091,95091,,,2310033,[],CHEMBL999241,Phytotoxicity against bent grass assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,6.0,CHEMBL613789,Poa nemoralis,Poa nemoralis,29659.0,,,Activity,mm2,,,6.0
95092,95092,,,2310034,[],CHEMBL999242,Phytotoxicity against rag weed assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,10.0,CHEMBL613801,Ambrosia artemisiifolia,Ambrosia artemisiifolia,4212.0,,,Activity,mm2,,,10.0
95093,95093,,,2310035,[],CHEMBL999243,Phytotoxicity against watercress assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,5.0,CHEMBL613228,Nasturtium officinale,Nasturtium officinale,65948.0,,,Activity,mm2,,,5.0
95094,95094,,,2310036,[],CHEMBL999244,Phytotoxicity against Jimsonweed assessed as leaf necrotic area at 50 ug by detached leaf assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,,763789,=,1,0,=,,Activity,mm2,,0.0,CHEMBL613964,Datura stramonium,Datura stramonium,4076.0,,,Activity,mm2,,,0.0
95095,95095,,,2310069,[],CHEMBL1000018,Antimicrobial activity against Escherichia coli at 500 ug by antibiotic disk assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,http://qudt.org/vocab/unit#Millimeter,763789,=,1,1,=,,IZ,mm,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Diameter of inhibition zone,mm,UO_0000016,,0.0
95096,95096,,,2310070,[],CHEMBL1000019,Antimicrobial activity against Agrobacterium tumefaciens at 500 ug by antibiotic disk assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,http://qudt.org/vocab/unit#Millimeter,763789,=,1,1,=,,IZ,mm,,0.0,CHEMBL612504,Agrobacterium tumefaciens,Agrobacterium tumefaciens,358.0,,,Diameter of inhibition zone,mm,UO_0000016,,0.0
95097,95097,,,2310071,[],CHEMBL1000020,Antimicrobial activity against Erwinia carotovora at 500 ug by antibiotic disk assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,http://qudt.org/vocab/unit#Millimeter,763789,=,1,1,=,,IZ,mm,,0.0,CHEMBL612990,Pectobacterium carotovorum,Pectobacterium carotovorum,554.0,,,Diameter of inhibition zone,mm,UO_0000016,,0.0
95098,95098,,,2310072,[],CHEMBL1000021,Antimicrobial activity against Corynebacterium flaccumfaciens at 500 ug by antibiotic disk assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,http://qudt.org/vocab/unit#Millimeter,763789,=,1,1,=,,IZ,mm,,12.0,CHEMBL613961,Curtobacterium flaccumfaciens,Curtobacterium flaccumfaciens,2035.0,,,Diameter of inhibition zone,mm,UO_0000016,,12.0
95099,95099,,,2310073,[],CHEMBL1000022,Antimicrobial activity against Aspergillus flavus at 500 ug by antibiotic disk assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,http://qudt.org/vocab/unit#Millimeter,763789,=,1,1,=,,IZ,mm,,10.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,Diameter of inhibition zone,mm,UO_0000016,,10.0
95100,95100,,,2310074,[],CHEMBL1000023,Antimicrobial activity against Penicillium notatum at 500 ug by antibiotic disk assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,http://qudt.org/vocab/unit#Millimeter,763789,=,1,1,=,,IZ,mm,,12.0,CHEMBL612847,Penicillium chrysogenum,Penicillium chrysogenum,5076.0,,,Diameter of inhibition zone,mm,UO_0000016,,12.0
95101,95101,,,2310075,[],CHEMBL1000024,Antimicrobial activity against Colletotrichum acutatum at 500 ug by antibiotic disk assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCC(C)c1oc(CC(C)O)cc(=O)c1C,,,CHEMBL1159020,J Nat Prod,1992.0,,CHEMBL455250,HYALOPYRONE,CHEMBL455250,,0,http://qudt.org/vocab/unit#Millimeter,763789,=,1,1,=,,IZ,mm,,16.0,CHEMBL2366942,Colletotrichum acutatum,Colletotrichum acutatum,27357.0,,,Diameter of inhibition zone,mm,UO_0000016,,16.0
95102,95102,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2351424,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '7.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '7.5'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL953899,"Cmax in human at 7.5 mg/kg, iv administered every 24 hrs",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,794536,=,1,1,=,,Cmax,nM,,50693.19,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,89.0
95103,95103,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2351425,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '7.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '7.5'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL956359,"Cmax in rabbit at 7.5 mg/kg, iv administered once daily",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,794536,=,1,1,=,,Cmax,nM,,51262.77,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,ug ml-1,UO_0000065,,90.0
95104,95104,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2351426,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL956361,"Cmax in rabbit at 10 mg/kg, iv administered once daily",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,794536,=,1,1,=,,Cmax,nM,,64932.85,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmax,ug ml-1,UO_0000065,,114.0
95105,95105,,,2351427,[],CHEMBL953900,"Cmin in human at 7.5 mg/kg, iv administered every 24 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794536,=,1,0,=,,Cmin,ug ml-1,,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmin,ug ml-1,UO_0000274,,6.0
95106,95106,,,2351428,[],CHEMBL956360,"Cmin in rabbit at 7.5 mg/kg, iv administered once daily",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794536,=,1,0,=,,Cmin,ug ml-1,,6.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmin,ug ml-1,UO_0000274,,6.0
95107,95107,,,2351429,[],CHEMBL956362,"Cmin in rabbit at 10 mg/kg, iv administered once daily",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794536,=,1,0,=,,Cmin,ug ml-1,,6.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Cmin,ug ml-1,UO_0000274,,6.0
95108,95108,,,2351430,[],CHEMBL953902,"Terminal half life in human at 7.5 mg/kg, iv administered every 24 hrs",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,794536,=,1,1,=,,T1/2,hr,,6.18,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,6.18
95109,95109,,,2351431,[],CHEMBL953903,"Terminal half life in human at 10 mg/kg, iv administered every 24 hrs",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,794536,=,1,1,=,,T1/2,hr,,7.41,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.41
95110,95110,,,2351432,[],CHEMBL956347,"Terminal half life in rabbit at 15 mg/kg, iv",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,794536,=,1,1,=,,T1/2,hr,,1.2,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,t1/2,hr,UO_0000032,,1.2
95111,95111,,,2351433,[],CHEMBL956354,"Terminal half life in rabbit at 7.5 mg/kg, iv administered once daily",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,794536,=,1,1,=,,T1/2,hr,,4.6,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,t1/2,hr,UO_0000032,,4.6
95112,95112,,,2351434,[],CHEMBL953905,"AUC in human at 7.5 mg/kg, iv administered every 24 hrs",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,1,=,,AUC,ng.hr.mL-1,,604000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,microg.hr/mL,,,604.0
95113,95113,,,2351435,[],CHEMBL956349,"AUC in rabbit at 15 mg/kg, iv",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,1,=,,AUC,ng.hr.mL-1,,269800.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,microg.hr/mL,,,269.8
95114,95114,,,2351436,[],CHEMBL956356,"AUC in rabbit at 7.5 mg/kg, iv administered once daily",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,1,=,,AUC,ng.hr.mL-1,,638000.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,AUC,microg.hr/mL,,,638.0
95115,95115,,,2351437,[],CHEMBL953906,"AUC in human at 10 mg/kg, iv administered every 24 hrs",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,1,=,,AUC,ng.hr.mL-1,,785000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,microg.hr/mL,,,785.0
95116,95116,,,2351438,[],CHEMBL953908,"Protein binding in human at 7.5 mg/kg, iv administered every 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,90.0
95117,95117,,,2351439,[],CHEMBL957192,"Protein binding in human at 10 mg/kg, iv administered every 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,90.0
95118,95118,,,2351440,[],CHEMBL956352,"Protein binding in rabbit at 10 mg/kg, iv",A,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,90.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,%,UO_0000187,,90.0
95119,95119,,,2351441,[],CHEMBL956351,"Protein binding in rabbit at 15 mg/kg, iv",A,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,90.0,CHEMBL374,Oryctolagus cuniculus,Oryctolagus cuniculus,9986.0,,,Activity,%,UO_0000187,,90.0
95120,95120,,,2351442,[],CHEMBL956364,"Ratio of AUC in rabbit at 7.5 mg/kg, iv qd to MIC for Staphylococcus aureus HIP 5836 isolate",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,RatioAUC/MIC,,,159.5,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,159.5
95121,95121,,,2351443,[],CHEMBL956365,"Ratio of AUC in rabbit at 7.5 mg/kg, iv qd to MIC for Staphylococcus aureus ATCC 700788",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,RatioAUC/MIC,,,638.0,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,638.0
95122,95122,,,2351450,[],CHEMBL956367,"Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus ATCC 700788 infected New Zealand white rabbit endocarditis model assessed as survival at 10 mg/kg, iv administered every 24 hrs for 2 days",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,94.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,94.0
95123,95123,,,2351451,[],CHEMBL956369,"Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus ATCC 700788 infected New Zealand white rabbit endocarditis model assessed as sterile bacterial vegetation at 10 mg/kg, iv administered every 24 hrs for 2 days",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,37.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,37.0
95124,95124,,,2351452,[],CHEMBL957176,"Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus HIP 5836 isolate infected New Zealand white rabbit endocarditis model assessed as survival at 10 mg/kg, iv administered every 24 hrs for 2 days",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,94.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,94.0
95125,95125,,,2351453,[],CHEMBL953924,"Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus HIP 5836 isolate infected New Zealand white rabbit endocarditis model assessed as sterile bacterial vegetation at 10 mg/kg, iv administered every 24 hrs for 2 days",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,794536,=,1,0,=,,Activity,%,,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,31.0
95126,95126,,,2351454,[],CHEMBL957174,"Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus ATCC 700788 infected New Zealand white rabbit endocarditis model assessed as bacterial count per gram of microbial vegetation at 10 mg/kg, iv administered every 24 hrs for 2 days",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,log10cfu,,,4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,4.6
95127,95127,,,2351455,[],CHEMBL953926,"Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus HIP 5836 isolate infected New Zealand white rabbit endocarditis model assessed as bacterial count per gram of microbial vegetation at 10 mg/kg, iv administered every 24 hrs for 2 days",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,log10cfu,,,4.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,4.4
95128,95128,,,2351456,[],CHEMBL953895,Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus HIP 5836 isolate by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794536,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,4.0
95129,95129,,,2351457,[],CHEMBL953895,Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus HIP 5836 isolate by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,MBC,mg/L,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/L,,,8.0
95130,95130,,,2351458,[],CHEMBL953894,Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus ATCC 700788 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794536,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
95131,95131,,,2351459,[],CHEMBL953894,Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus ATCC 700788 by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,MBC,mg/L,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/L,,,4.0
95132,95132,,,2351464,[],CHEMBL953896,Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus HIP 5836 isolate assessed as reduction of bacterial count after 24 hrs by time kill curve study,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,log10CFU/ml,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.0
95133,95133,,,2351465,[],CHEMBL953897,Antibacterial activity against glycopeptide-intermediate resistant Staphylococcus aureus ATCC 700788 assessed as reduction of bacterial count after 24 hrs by time kill curve study,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1157365,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,794536,=,1,0,=,,log10CFU/ml,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.0
95134,95134,,,2496164,[],CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.06
95135,95135,,,2496174,[],CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.06
95136,95136,,,2496184,[],CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,mg/L,UO_0000274,,0.12
95137,95137,,,2496194,[],CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,mg/L,UO_0000274,,0.12
95138,95138,,,2496204,[],CHEMBL983324,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg/L,UO_0000274,,0.015
95139,95139,,,2496210,[],CHEMBL983325,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg/L,UO_0000274,,0.25
95140,95140,,,2496216,[],CHEMBL983326,Antibacterial activity against vancomycin-susceptible Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,mg/L,UO_0000274,,0.03
95141,95141,,,2496222,[],CHEMBL983327,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,mg/L,UO_0000274,,0.12
95142,95142,,,2496228,[],CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.008
95143,95143,,,2496239,[],CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.008
95144,95144,,,2496250,[],CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.015
95145,95145,,,2496261,[],CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC,mg/L,UO_0000274,,0.03
95146,95146,,,2496272,[],CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,mg/L,UO_0000274,,0.03
95147,95147,,,2497048,[],CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,mg/L,UO_0000274,,0.015
95148,95148,,,2497059,[],CHEMBL986881,Plasma concentration in human at 7.5 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,0,=,,Cp,ug ml-1,,96.7,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,96.7
95149,95149,,,2497060,[],CHEMBL986882,Protein binding in human plasma,A,,,BAO_0000179,BAO_0000366,cell-free format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,780046,=,1,1,=,,PPB,%,,90.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,PB,%,UO_0000187,,90.0
95150,95150,,,2497061,[],CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.25
95151,95151,,,2497071,[],CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.25
95152,95152,,,2497081,[],CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,mg/L,UO_0000274,,0.25
95153,95153,,,2497091,[],CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,mg/L,UO_0000274,,0.25
95154,95154,,,2497101,[],CHEMBL983324,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,mg/L,UO_0000274,,0.25
95155,95155,,,2497107,[],CHEMBL983325,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,mg/L,UO_0000274,,4.0
95156,95156,,,2497113,[],CHEMBL983326,Antibacterial activity against vancomycin-susceptible Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,mg/L,UO_0000274,,0.12
95157,95157,,,2497119,[],CHEMBL983327,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,mg/L,UO_0000274,,1.0
95158,95158,,,2497125,[],CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,mg/L,UO_0000274,,0.015
95159,95159,,,2497136,[],CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,mg/L,UO_0000274,,0.015
95160,95160,,,2497147,[],CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,mg/L,UO_0000274,,0.015
95161,95161,,,2497158,[],CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC50,mg/L,UO_0000274,,0.03
95162,95162,,,2497169,[],CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC50,mg/L,UO_0000274,,0.06
95163,95163,,,2497180,[],CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,mg/L,UO_0000274,,0.06
95164,95164,,,2497191,[],CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.25
95165,95165,,,2497201,[],CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.25
95166,95166,,,2497211,[],CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,mg/L,UO_0000274,,0.25
95167,95167,,,2497221,[],CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,mg/L,UO_0000274,,0.25
95168,95168,,,2497231,[],CHEMBL983324,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,mg/L,UO_0000274,,0.5
95169,95169,,,2497237,[],CHEMBL983325,Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,mg/L,UO_0000274,,8.0
95170,95170,,,2497243,[],CHEMBL983326,Antibacterial activity against vancomycin-susceptible Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,mg/L,UO_0000274,,0.25
95171,95171,,,2497249,[],CHEMBL983327,Antibacterial activity against vancomycin-resistant Enterococcus faecium after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,mg/L,UO_0000274,,2.0
95172,95172,,,2497255,[],CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.03
95173,95173,,,2497266,[],CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.03
95174,95174,,,2497277,[],CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.03
95175,95175,,,2497288,[],CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC90,mg/L,UO_0000274,,0.06
95176,95176,,,2497299,[],CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC90,mg/L,UO_0000274,,0.06
95177,95177,,,2497310,[],CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780046,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,mg/L,UO_0000274,,0.06
95178,95178,,,2498097,[],CHEMBL1021583,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 1 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.3
95179,95179,,,2498098,[],CHEMBL1021582,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 1 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.6
95180,95180,,,2498099,[],CHEMBL1021581,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 2.5 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.2
95181,95181,,,2498100,[],CHEMBL1021580,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 2.5 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.7
95182,95182,,,2498101,[],CHEMBL1021579,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 2.5 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.7
95183,95183,,,2498102,[],CHEMBL1021578,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 2.5 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.2
95184,95184,,,2498103,[],CHEMBL1021577,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 2.5 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.2
95185,95185,,,2498104,[],CHEMBL1021576,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 2.5 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.6
95186,95186,,,2498105,[],CHEMBL1021575,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 5 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-0.9
95187,95187,,,2498106,[],CHEMBL1021574,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 5 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.1
95188,95188,,,2498107,[],CHEMBL1021573,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 5 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.1
95189,95189,,,2498108,[],CHEMBL1021572,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 5 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.6
95190,95190,,,2498109,[],CHEMBL1021571,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 5 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.2
95191,95191,,,2498110,[],CHEMBL1021570,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 5 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.6
95192,95192,,,2498111,[],CHEMBL1021569,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 10 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.2
95193,95193,,,2498112,[],CHEMBL1021568,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 10 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.2
95194,95194,,,2498113,[],CHEMBL1021567,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 10 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.0
95195,95195,,,2498114,[],CHEMBL1021566,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 10 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.8
95196,95196,,,2498115,[],CHEMBL1021565,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 10 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-5.1
95197,95197,,,2498116,[],CHEMBL1021564,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 10 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-5.1
95198,95198,,,2498117,[],CHEMBL1010697,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 20 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.0
95199,95199,,,2498118,[],CHEMBL1029785,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 20 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.1
95200,95200,,,2498119,[],CHEMBL1029786,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 20 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.6
95201,95201,,,2498120,[],CHEMBL1029787,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 20 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.5
95202,95202,,,2498121,[],CHEMBL1029788,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 20 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95203,95203,,,2498122,[],CHEMBL1029789,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 20 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95204,95204,,,2498123,[],CHEMBL1029790,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 40 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.2
95205,95205,,,2498124,[],CHEMBL1029791,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 40 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.7
95206,95206,,,2498125,[],CHEMBL1029792,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 40 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.9
95207,95207,,,2498126,[],CHEMBL1029793,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 40 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.5
95208,95208,,,2498127,[],CHEMBL1029794,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 40 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.6
95209,95209,,,2498128,[],CHEMBL1029795,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 40 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.6
95210,95210,,Dose-dependent effect,2498129,[],CHEMBL1029796,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 in MH-broth,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95211,95211,,,2498130,[],CHEMBL1029797,Protein binding in human plasma,A,,,BAO_0001103,BAO_0000366,cell-free format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,779202,=,1,0,=,,Activity,%,,92.0,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,Activity,%,UO_0000187,,92.0
95212,95212,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2501312,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '7.5', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '7.5'}]",CHEMBL1009786,Cmax in human serum at 7.5 mg/kg,A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,779202,=,1,1,=,,Cmax,nM,,34175.18,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,mg/L,UO_0000065,,60.0
95213,95213,,,2501313,[],CHEMBL1010668,Half life in human serum at 7.5 mg/kg,A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,779202,=,1,1,=,,T1/2,hr,,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,7.0
95214,95214,,,2501314,[],CHEMBL1010669,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 after 18 to 24 hrs by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779202,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
95215,95215,,,2501315,[],CHEMBL1010670,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 18 to 24 hrs by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779202,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
95216,95216,,Active,2501316,[],CHEMBL1010671,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial regrowth at 0.25 times MIC,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95217,95217,,,2501317,[],CHEMBL1010672,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial killing at 0.5 to 50 times MIC after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,>,1,0,>,,LCK,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,LCK,,,,3.0
95218,95218,,Active,2501318,[],CHEMBL1010673,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial killing at 50 times MIC after 24 hrs in presence of human albumin,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95219,95219,,Active,2501319,[],CHEMBL1010674,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial regrowth at 0.5 times MIC after 24 hrs in presence of human albumin,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95220,95220,,Active,2501320,[],CHEMBL1010675,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial regrowth at 1 times MIC after 24 hrs in presence of human albumin,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95221,95221,,,2501321,[],CHEMBL1010676,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing at 2.5 to 50 times MIC after 24 hrs in presence of human albumin,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,>,1,0,>,,LCK,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,LCK,,,,3.0
95222,95222,,Active,2501322,[],CHEMBL1010677,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing at 50 times MIC after 24 hrs in presence of human albumin,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95223,95223,,Active,2501323,[],CHEMBL1010678,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing at 50 times MIC after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95224,95224,,Active,2501324,[],CHEMBL1010679,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing at 0.5 to 50 times MIC after 24 hrs in presence of 50% human serum,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95225,95225,,Active,2501325,[],CHEMBL1010680,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial killing at 0.5 to 50 times MIC after 24 hrs in presence of 50% human serum,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95226,95226,,Active,2501326,[],CHEMBL1010681,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial killing at 10 times MIC after 6 hrs in MH-broth,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95227,95227,,Active,2501327,[],CHEMBL1010682,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial killing at 10 times MIC after 6 hrs in PBS-nutrient depleted medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95228,95228,,Active,2501328,[],CHEMBL1010683,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing at 10 times MIC after 6 hrs in MH-broth,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95229,95229,,Active,2501329,[],CHEMBL1010684,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing at 10 times MIC after 24 hrs in PBS-nutrient depleted medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95230,95230,,Active,2501330,[],CHEMBL1010685,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing at 10 times MIC after 24 hrs in MH-broth,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95231,95231,,,2501331,[],CHEMBL1010686,Half life in in vitro kinetic model containing Mueller-Hinton broth and bacteria,P,,,BAO_0002115,BAO_0000100,small-molecule physicochemical format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,779202,=,1,1,=,,T1/2,hr,,8.0,CHEMBL2362975,,No relevant target,,,,t1/2,hr,UO_0000032,,8.0
95232,95232,,Active,2501332,[],CHEMBL1010687,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial regrowth at 5 mg/liter Cmax,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95233,95233,,Not Active,2501333,[],CHEMBL1010688,Ratio of AUC in in vitro kinetic model containing Mueller-Hinton broth and methicillin-susceptible Staphylococcus aureus ATCC 13709 to MIC for methicillin-susceptible Staphylococcus aureus ATCC 13709 in bacterial regrowth stage,F,,,BAO_0000375,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
95234,95234,,Active,2501334,[],CHEMBL1010689,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as bacterial regrowth at 40 mg/liter Cmax,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95235,95235,,,2501335,[],CHEMBL1010690,Ratio of AUC in in vitro kinetic model containing Mueller-Hinton broth and methicillin-susceptible Staphylococcus aureus ATCC 13709 to MIC for methicillin-susceptible Staphylococcus aureus ATCC 13709 in bacterial killing stage,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,RatioAUC/MIC,,,404.0,CHEMBL612545,,Unchecked,,,,RatioAUC/MIC,,,,404.0
95236,95236,,,2501336,[],CHEMBL1010691,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 1 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-0.8
95237,95237,,,2501337,[],CHEMBL1010692,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 1 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.3
95238,95238,,,2501338,[],CHEMBL1010693,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 1 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.0
95239,95239,,,2501339,[],CHEMBL1010694,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 1 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.6
95240,95240,,,2501340,[],CHEMBL1010695,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 1 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.6
95241,95241,,,2501341,[],CHEMBL1010696,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 1 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-0.5
95242,95242,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2501342,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}]",CHEMBL1029782,Cmax in human at 10 mg/kg once daily,A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,779202,=,1,1,=,,Cmax,nM,,2961.85,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,mg/L,UO_0000065,,5.2
95243,95243,,,2501343,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1029783,AUC (0 to 24 hrs) in human at 10 mg/kg once daily,A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,1,=,,AUC,ng.hr.mL-1,,51000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,51.0
95244,95244,,,2501344,[],CHEMBL1029784,"Antibacterial activity against methicillin-resistant Staphylococcus aureus COL infected New Zealand white rabbit endocarditis model assessed as reduction in mean aortic vegetation titer at 30 mg/kg, iv twice daily after 4 days",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,log10CFU/g,,,4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/g,,,,4.7
95245,95245,,,2501345,[],CHEMBL1029781,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 2.5 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.1
95246,95246,,,2501346,[],CHEMBL1029780,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 2.5 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.6
95247,95247,,,2501347,[],CHEMBL1029779,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 2.5 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.6
95248,95248,,,2501348,[],CHEMBL1029778,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 2.5 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.4
95249,95249,,,2501349,[],CHEMBL1029777,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 2.5 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95250,95250,,,2501350,[],CHEMBL1029776,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 2.5 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.9
95251,95251,,,2501351,[],CHEMBL1029775,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 5 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.2
95252,95252,,,2501352,[],CHEMBL1029774,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 5 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.3
95253,95253,,,2501353,[],CHEMBL1031612,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 5 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.4
95254,95254,,,2501354,[],CHEMBL1031611,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 5 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.0
95255,95255,,,2501355,[],CHEMBL1031610,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 5 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95256,95256,,,2501356,[],CHEMBL1031609,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 5 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95257,95257,,,2501357,[],CHEMBL1031608,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 10 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.2
95258,95258,,,2501358,[],CHEMBL1031607,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 10 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.4
95259,95259,,,2501359,[],CHEMBL1031606,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 10 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.3
95260,95260,,,2501360,[],CHEMBL1031605,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 10 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.3
95261,95261,,,2501361,[],CHEMBL1031604,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 10 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.5
95262,95262,,,2501362,[],CHEMBL1031603,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 10 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.5
95263,95263,,,2501363,[],CHEMBL1031602,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 20 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.3
95264,95264,,,2501364,[],CHEMBL1031601,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 20 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.9
95265,95265,,,2501365,[],CHEMBL1031600,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 20 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.9
95266,95266,,,2501366,[],CHEMBL1031599,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 20 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.6
95267,95267,,,2501367,[],CHEMBL1031598,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 20 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.6
95268,95268,,,2501368,[],CHEMBL1031597,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 20 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.6
95269,95269,,,2501369,[],CHEMBL1031596,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 40 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.9
95270,95270,,,2501370,[],CHEMBL1031595,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 40 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.8
95271,95271,,,2501371,[],CHEMBL1031594,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 40 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95272,95272,,,2501372,[],CHEMBL1031593,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 40 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95273,95273,,,2501373,[],CHEMBL1031592,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 40 mg/liter after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95274,95274,,,2501374,[],CHEMBL1031591,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 assessed as change in bacterial burden at 40 mg/liter after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-4.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-4.7
95275,95275,,,2501375,[],CHEMBL1031590,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 1 mg/liter after 2 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.0
95276,95276,,,2501376,[],CHEMBL1031589,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 1 mg/liter after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-1.9
95277,95277,,,2501377,[],CHEMBL1021585,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 1 mg/liter after 6 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-2.9
95278,95278,,,2501378,[],CHEMBL1021584,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as change in bacterial burden at 1 mg/liter after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1154419,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,779202,=,1,0,=,,deltalog10CFU/ml,,,-3.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,deltalog10CFU/ml,,,,-3.5
95279,95279,,,2661607,[],CHEMBL1035446,Protein binding in mouse plasma at 0.1 to 100 ug/mL by equilibrium dialysis,A,,,BAO_0000179,BAO_0000366,cell-free format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,818068,=,1,1,=,,PPB,%,,95.0,CHEMBL613589,Mus musculus,Plasma,10090.0,,,PB,%,UO_0000187,,95.0
95280,95280,,Active,2661608,[],CHEMBL1035445,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 in peritoneal dialysis fluid at 10 ug/mL administered as bolus dose 2 hrs after infection measured after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,818068,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95281,95281,,Active,2661609,[],CHEMBL1035447,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 in peritoneal dialysis fluid at 50 ug/mL administered as bolus dose 2 hrs after infection measured after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,818068,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95282,95282,,Active,2661610,[],CHEMBL1035448,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 in peritoneal dialysis fluid at 10 ug/mL administered as bolus dose 2 hrs after infection measured after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,818068,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95283,95283,,Active,2661611,[],CHEMBL1035449,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 in peritoneal dialysis fluid at 50 ug/mL administered as bolus dose 2 hrs after infection measured after 24 hrs by time-kill study,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,818068,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95284,95284,,,2661616,[],CHEMBL1035450,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 in peritoneal dialysis fluid administered as bolus dose 2 hrs after infection measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818068,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95285,95285,,,2661617,[],CHEMBL1035451,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 in peritoneal dialysis fluid administered as bolus dose 2 hrs after infection measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1151436,Antimicrob Agents Chemother,2007.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818068,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95286,95286,,,2723048,[],CHEMBL1063658,"Drug level in alveolar macrophage of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 8 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Drug uptake,ug ml-1,,19.0,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,19.0
95287,95287,,,2723049,[],CHEMBL1061832,"Ratio of drug level in epithelial lining fluid of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days to antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591",U,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,0,=,,Ratio,,,8.0,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,8.0
95288,95288,,,2723050,[],CHEMBL1063646,Antibacterial activity against methicillin-susceptible Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95289,95289,,,2723051,[],CHEMBL1063647,Antibacterial activity against methicillin-susceptible Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.03
95290,95290,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,2723052,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1063648,"Cmax in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,829539,=,1,1,=,,Cmax,nM,,66072.02,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,116.0
95291,95291,,,2723053,[],CHEMBL1063649,"Tmax in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0003037,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,829539,=,1,1,=,,Tmax,hr,,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Tmax,hr,UO_0000032,,1.0
95292,95292,,,2723054,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1063650,"AUC (0 to 24) in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,1,=,,AUC,ng.hr.mL-1,,785000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,785.0
95293,95293,,,2723055,[],CHEMBL1063651,"Terminal half life in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,829539,=,1,1,=,,T1/2,hr,,7.41,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,beta t1/2,hr,UO_0000032,,7.41
95294,95294,,,2723056,[],CHEMBL1063652,"Clearance at steady state in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,1,=,,CL,mL.min-1.kg-1,,0.2167,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CLss,ml/hr.kg,,,13.0
95295,95295,,,2723057,[],CHEMBL1063653,"Mean residence time in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,829539,=,1,1,=,,MRT,hr,,9.42,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,MRT,hr,UO_0000032,,9.42
95296,95296,,,2723058,[],CHEMBL1063654,"Volume of distribution at steady state in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,1,=,,Vdss,L.kg-1,,0.122,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Vdss,ml/kg,UO_0000197,,122.0
95297,95297,,,2723059,[],CHEMBL1063655,"Cmin in healthy human at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Cmin,ug ml-1,,8.11,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmin,ug ml-1,UO_0000274,,8.11
95298,95298,,,2723060,[],CHEMBL1063656,"Drug level in epithelial lining fluid of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 8 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Drug uptake,ug ml-1,,3.7,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,3.7
95299,95299,,,2723061,[],CHEMBL1063657,"Drug level in epithelial lining fluid of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 24 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Drug uptake,ug ml-1,,0.9,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,0.9
95300,95300,,,2723062,[],CHEMBL1063659,"Drug level in alveolar macrophage of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 12 after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Drug uptake,ug ml-1,,45.0,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,45.0
95301,95301,,,2723063,[],CHEMBL1052787,"Drug level in alveolar macrophage of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 24 after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Drug uptake,ug ml-1,,42.0,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,42.0
95302,95302,,,2723064,[],CHEMBL1052788,"Ratio of drug level in alveolar macrophage to epithelial lining fluid of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 4 hrs after start of infusion",A,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,0,=,,Ratio,,,8.3,CHEMBL612558,,ADMET,,,,Ratio,,,,8.3
95303,95303,,,2723065,[],CHEMBL1052789,"Ratio of drug level in alveolar macrophage to epithelial lining fluid of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 8 hrs after start of infusion",A,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,0,=,,Ratio,,,4.8,CHEMBL612558,,ADMET,,,,Ratio,,,,4.8
95304,95304,,,2723066,[],CHEMBL1052790,"Plasma concentration in healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 12 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Cp,ug ml-1,,22.9,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,22.9
95305,95305,,,2723067,[],CHEMBL1061826,"Plasma protein binding in healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,829539,=,1,1,=,,PPB,%,,90.0,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,PPB,%,UO_0000187,,90.0
95306,95306,,,2723068,[],CHEMBL1052792,"Ratio of drug level in alveolar macrophage to plasma of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 12 hrs after start of infusion",A,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,0,=,,Ratio,,,1.93,CHEMBL612558,,ADMET,,,,Ratio,,,,1.93
95307,95307,,,2723069,[],CHEMBL1052791,"Plasma concentration in healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 24 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Cp,ug ml-1,,7.28,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,7.28
95308,95308,,,2723070,[],CHEMBL1052793,"Ratio of drug level in alveolar macrophage to plasma of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days measured at 24 hrs after start of infusion",A,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,0,=,,Ratio,,,6.67,CHEMBL612558,,ADMET,,,,Ratio,,,,6.67
95309,95309,,,2723071,[],CHEMBL1052794,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by CLSI broth microdilution method,F,,,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Activity,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,ug ml-1,UO_0000274,,0.5
95310,95310,,Active,2723072,[],CHEMBL1053523,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by standard checkerboard method in presence of 0.2 to 1 mg/ml pulmonar surfactant,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95311,95311,,Active,2723073,[],CHEMBL1053524,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by standard checkerboard method in presence of 0.2 to 1 mg/ml pulmonar surfactant,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
95312,95312,,Non-toxic,2723082,[],CHEMBL1056806,"Toxicity in healthy human at 10 mg/kg, iv once daily for 3 days by clinical laboratory test",T,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
95313,95313,,Non-toxic,2723083,[],CHEMBL1056807,"Toxicity in healthy human assessed as pulmonar inflammation at 10 mg/kg, iv once daily for 3 days",T,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
95314,95314,,Non-toxic,2723084,[],CHEMBL1056808,"Toxicity in healthy human assessed as pulmonar infection at 10 mg/kg, iv once daily for 3 days",T,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
95315,95315,,,2723085,[],CHEMBL1061825,"Ratio of drug level in alveolar macrophage of healthy human undergoing fiber-optic bronchoscopy at 10 mg/kg, iv once daily for 3 days to antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591",U,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,0,=,,Ratio,,,38.0,CHEMBL345,,Nucleic Acid,,,,Ratio,,,,38.0
95316,95316,,,2723086,[],CHEMBL1061827,"Plasma concentration in healthy human undergoing fiber-optic bronchoscopy at 1g, iv twice daily for 3 days measured at 12 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Cp,ug ml-1,,5.1,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cp,ug ml-1,UO_0000274,,5.1
95317,95317,,,2723087,[],CHEMBL1061828,"Drug level in epithelial lining fluid of healthy human undergoing fiber-optic bronchoscopy at 1g, iv twice daily for 3 days measured at 12 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Drug uptake,ug ml-1,,2.4,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,2.4
95318,95318,,,2723088,[],CHEMBL1061829,"Drug level in alveolar macrophage of healthy human undergoing fiber-optic bronchoscopy at 1g, iv twice daily for 3 days measured at 12 hrs after start of infusion by validated liquid chromatography",A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,0,=,,Drug uptake,ug ml-1,,45.2,CHEMBL612558,,ADMET,,,,Drug uptake,ug ml-1,UO_0000274,,45.2
95319,95319,,,2723089,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1061830,"AUC (0 to 24) in epithelial lining fluid of healthy human at 10 mg/kg, iv once daily for 3 days",A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,1,=,,AUC,ng.hr.mL-1,,45000.0,CHEMBL612558,,ADMET,,,,AUC,microg/hr/ml,,,45.0
95320,95320,,,2723090,[],CHEMBL1061831,"Ratio of AUC (0 to 24) in epithelial lining fluid of healthy human at 10 mg/kg, iv once daily for 3 days to antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591",F,,,BAO_0000193,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,0,=,,Ratio,,,90.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Ratio,,,,90.0
95321,95321,,,2723091,[],CHEMBL1061833,fAUC (0 to 24) in mouse pneumonia model at 40 mg/kg,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,=,1,1,=,,fAUC,ng.hr.mL-1,,52300.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,fAUC,microg/hr/ml,,,52.3
95322,95322,,Non-toxic,2723092,[],CHEMBL1061834,Toxicity in healthy human at 10 mg/kg/day infused over 1 hr,T,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,829539,,1,0,,,Activity,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,,,,
95323,95323,,,2723093,[],CHEMBL1061835,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95324,95324,,,2723094,[],CHEMBL1061836,Antibacterial activity against methicillin-resistant Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1153549,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829539,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.03
95325,95325,,,3479660,[],CHEMBL1268379,Antibacterial activity against linezolid/daptomycin-nonsusceptible vancomycin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
95326,95326,,,3479661,[],CHEMBL1268378,Antibacterial activity against linezolid/daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
95327,95327,,,3479662,[],CHEMBL1268377,Antibacterial activity against linezolid/daptomycin-nonsusceptible vancomycin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.06
95328,95328,,,3479663,[],CHEMBL1268376,"Antibacterial activity against vancomycin-, methicillin-resistant Staphylococcus aureus VRS3 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
95329,95329,,,3479664,[],CHEMBL1268375,"Antibacterial activity against vancomycin-, methicillin-resistant Staphylococcus aureus VRS2 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
95330,95330,,,3479665,[],CHEMBL1268374,"Antibacterial activity against vancomycin-, methicillin-resistant Staphylococcus aureus VRS1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
95331,95331,,,3479666,[],CHEMBL1268373,Antibacterial activity against vancomycin-intermediate methicillin-susceptible Staphylococcus aureus NRS56 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
95332,95332,,,3479667,[],CHEMBL1268282,Antibacterial activity against vancomycin-intermediate methicillin-resistant Staphylococcus aureus NRS12 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95333,95333,,,3479668,[],CHEMBL1268281,Antibacterial activity against vancomycin-intermediate methicillin-resistant Staphylococcus aureus NRS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95334,95334,,,3479669,[],CHEMBL1268280,Antibacterial activity against vancomycin-intermediate methicillin-resistant Staphylococcus aureus NRS118 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95335,95335,,,3479670,[],CHEMBL1268279,Antibacterial activity against vancomycin-intermediate methicillin-resistant Staphylococcus aureus NRS74 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
95336,95336,,,3479671,[],CHEMBL1268278,Antibacterial activity against vancomycin-intermediate methicillin-resistant Staphylococcus aureus NRS17 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
95337,95337,,,3479672,[],CHEMBL1268277,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus capitis isolate 1285355 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC,ug ml-1,UO_0000274,,1.0
95338,95338,,,3479673,[],CHEMBL1268276,Antibacterial activity against daptomycin-nonsusceptible coagulase-negative Staphylococcus isolate 1285835 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.5
95339,95339,,,3479674,[],CHEMBL1268275,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1585404 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95340,95340,,,3479675,[],CHEMBL1268274,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1176127 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95341,95341,,,3479676,[],CHEMBL1268273,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1171063 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95342,95342,,,3479677,[],CHEMBL1267830,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus isolate 1171055 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95343,95343,,,3479678,[],CHEMBL1267829,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
95344,95344,,,3479679,[],CHEMBL1267829,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.015
95345,95345,,,3479680,[],CHEMBL1267829,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.015
95346,95346,,,3479681,[],CHEMBL1267828,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
95347,95347,,,3479682,[],CHEMBL1267828,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.015
95348,95348,,,3479683,[],CHEMBL1267828,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.015
95349,95349,,,3479684,[],CHEMBL1267827,Antibacterial activity against penicillin susceptible Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.002
95350,95350,,,3479685,[],CHEMBL1267827,Antibacterial activity against penicillin susceptible Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.03
95351,95351,,,3479686,[],CHEMBL1267827,Antibacterial activity against penicillin susceptible Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.015
95352,95352,,,3479687,[],CHEMBL1267826,Antibacterial activity against Streptococcus sp. clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC,ug ml-1,UO_0000274,,0.001
95353,95353,,,3479688,[],CHEMBL1267826,Antibacterial activity against Streptococcus sp. clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC90,ug ml-1,UO_0000274,,0.12
95354,95354,,,3479689,[],CHEMBL1267826,Antibacterial activity against Streptococcus sp. clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95355,95355,,,3479690,[],CHEMBL1267825,Antibacterial activity against Streptococcus sanguinis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC,ug ml-1,UO_0000274,,0.001
95356,95356,,,3479691,[],CHEMBL1267825,Antibacterial activity against Streptococcus sanguinis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC90,ug ml-1,UO_0000274,,0.12
95357,95357,,,3479692,[],CHEMBL1267825,Antibacterial activity against Streptococcus sanguinis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95358,95358,,,3479693,[],CHEMBL1267824,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,0.001
95359,95359,,,3479694,[],CHEMBL1267824,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC90,ug ml-1,UO_0000274,,0.12
95360,95360,,,3479695,[],CHEMBL1267824,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95361,95361,,,3479696,[],CHEMBL1267823,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.001
95362,95362,,,3479697,[],CHEMBL1267823,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC90,ug ml-1,UO_0000274,,0.12
95363,95363,,,3479698,[],CHEMBL1267823,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95364,95364,,,3479699,[],CHEMBL1267822,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC,ug ml-1,UO_0000274,,0.001
95365,95365,,,3479700,[],CHEMBL1267822,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC90,ug ml-1,UO_0000274,,0.12
95366,95366,,,3479701,[],CHEMBL1267822,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95367,95367,,,3479702,[],CHEMBL1267821,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC,ug ml-1,UO_0000274,,0.001
95368,95368,,,3479703,[],CHEMBL1267821,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC90,ug ml-1,UO_0000274,,0.12
95369,95369,,,3479704,[],CHEMBL1267821,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95370,95370,,,3479705,[],CHEMBL1267820,Antibacterial activity against Streptococcus bovis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,0.001
95371,95371,,,3479706,[],CHEMBL1267820,Antibacterial activity against Streptococcus bovis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC90,ug ml-1,UO_0000274,,0.12
95372,95372,,,3479707,[],CHEMBL1267820,Antibacterial activity against Streptococcus bovis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95373,95373,,,3479708,[],CHEMBL1267819,Antibacterial activity against Streptococcus sp. Group G clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
95374,95374,,,3479709,[],CHEMBL1267819,Antibacterial activity against Streptococcus sp. Group G clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.06
95375,95375,,,3479710,[],CHEMBL1267819,Antibacterial activity against Streptococcus sp. Group G clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.03
95376,95376,,,3479711,[],CHEMBL1267818,Antibacterial activity against Streptococcus sp. Group F clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC,ug ml-1,UO_0000274,,0.03
95377,95377,,,3479712,[],CHEMBL1267818,Antibacterial activity against Streptococcus sp. Group F clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC90,ug ml-1,UO_0000274,,0.06
95378,95378,,,3479713,[],CHEMBL1267818,Antibacterial activity against Streptococcus sp. Group F clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95379,95379,,,3479714,[],CHEMBL1267817,Antibacterial activity against Streptococcus sp. Group C clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
95380,95380,,,3479715,[],CHEMBL1267817,Antibacterial activity against Streptococcus sp. Group C clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.06
95381,95381,,,3479716,[],CHEMBL1267817,Antibacterial activity against Streptococcus sp. Group C clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.03
95382,95382,,,3479717,[],CHEMBL1267816,Antibacterial activity against Streptococcus agalactiae clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.03
95383,95383,,,3479718,[],CHEMBL1267816,Antibacterial activity against Streptococcus agalactiae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.06
95384,95384,,,3479719,[],CHEMBL1267816,Antibacterial activity against Streptococcus agalactiae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.06
95385,95385,,,3479720,[],CHEMBL1267815,Antibacterial activity against Streptococcus pyogenes clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.015
95386,95386,,,3479721,[],CHEMBL1267815,Antibacterial activity against Streptococcus pyogenes clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.06
95387,95387,,,3479722,[],CHEMBL1267815,Antibacterial activity against Streptococcus pyogenes clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95388,95388,,,3479723,[],CHEMBL1267776,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.12
95389,95389,,,3479724,[],CHEMBL1267776,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,2.0
95390,95390,,,3479725,[],CHEMBL1267776,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95391,95391,,,3479726,[],CHEMBL1267775,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.015
95392,95392,,,3479727,[],CHEMBL1267775,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,8.0
95393,95393,,,3479728,[],CHEMBL1267775,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,4.0
95394,95394,,,3479729,[],CHEMBL1267774,Antibacterial activity against vancomycin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.015
95395,95395,,,3479730,[],CHEMBL1267774,Antibacterial activity against vancomycin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95396,95396,,,3479731,[],CHEMBL1267774,Antibacterial activity against vancomycin-susceptible Enterococcus faecium clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95397,95397,,,3479732,[],CHEMBL1267773,Antibacterial activity against vancomycin-resistant and teichoplanin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
95398,95398,,,3479733,[],CHEMBL1267772,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
95399,95399,,,3479734,[],CHEMBL1267772,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
95400,95400,,,3479735,[],CHEMBL1267772,Antibacterial activity against vancomycin- and teichoplanin-nonsusceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,8.0
95401,95401,,,3479736,[],CHEMBL1267771,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.12
95402,95402,,,3479737,[],CHEMBL1267771,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,1.0
95403,95403,,,3479738,[],CHEMBL1267771,Antibacterial activity against vancomycin-susceptible Enterococcus faecalis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95404,95404,,,3479739,[],CHEMBL1267770,Antibacterial activity against methicillin-resistant coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.12
95405,95405,,,3479740,[],CHEMBL1267770,Antibacterial activity against methicillin-resistant coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95406,95406,,,3479741,[],CHEMBL1267770,Antibacterial activity against methicillin-resistant coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95407,95407,,,3479742,[],CHEMBL1267769,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,,MIC,ug ml-1,UO_0000274,,0.12
95408,95408,,,3479743,[],CHEMBL1267769,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95409,95409,,,3479744,[],CHEMBL1267769,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95410,95410,,,3479745,[],CHEMBL1267768,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC,ug ml-1,UO_0000274,,0.12
95411,95411,,,3479746,[],CHEMBL1267768,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95412,95412,,,3479747,[],CHEMBL1267768,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95413,95413,,,3479748,[],CHEMBL1267767,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC,ug ml-1,UO_0000274,,0.12
95414,95414,,,3479749,[],CHEMBL1267767,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95415,95415,,,3479750,[],CHEMBL1267767,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95416,95416,,,3479751,[],CHEMBL1267766,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC,ug ml-1,UO_0000274,,0.12
95417,95417,,,3479752,[],CHEMBL1267766,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95418,95418,,,3479753,[],CHEMBL1267766,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95419,95419,,,3479754,[],CHEMBL1267765,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.12
95420,95420,,,3479755,[],CHEMBL1267765,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95421,95421,,,3479756,[],CHEMBL1267765,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95422,95422,,,3479757,[],CHEMBL1267764,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,0.12
95423,95423,,,3479758,[],CHEMBL1267764,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95424,95424,,,3479759,[],CHEMBL1267764,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95425,95425,,,3479760,[],CHEMBL1267763,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.12
95426,95426,,,3479761,[],CHEMBL1267763,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95427,95427,,,3479762,[],CHEMBL1267763,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95428,95428,,,3479763,[],CHEMBL1267762,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
95429,95429,,,3479764,[],CHEMBL1267762,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95430,95430,,,3479765,[],CHEMBL1267762,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95431,95431,,,3479766,[],CHEMBL1267761,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,,MIC,ug ml-1,UO_0000274,,0.12
95432,95432,,,3479767,[],CHEMBL1267761,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95433,95433,,,3479768,[],CHEMBL1267761,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95434,95434,,,3479769,[],CHEMBL1267760,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC,ug ml-1,UO_0000274,,0.12
95435,95435,,,3479770,[],CHEMBL1267760,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95436,95436,,,3479771,[],CHEMBL1267760,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95437,95437,,,3479772,[],CHEMBL1267759,Antibacterial activity against methicillin-susceptible coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,ug ml-1,UO_0000274,,0.06
95438,95438,,,3479773,[],CHEMBL1267759,Antibacterial activity against methicillin-susceptible coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95439,95439,,,3479774,[],CHEMBL1267759,Antibacterial activity against methicillin-susceptible coagulase-negative unspeciated Staphylococcus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95440,95440,,,3480140,[],CHEMBL1267758,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95441,95441,,,3480141,[],CHEMBL1267758,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95442,95442,,,3480142,[],CHEMBL1267757,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC,ug ml-1,UO_0000274,,0.06
95443,95443,,,3480143,[],CHEMBL1267757,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95444,95444,,,3480144,[],CHEMBL1267757,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus warneri clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95445,95445,,,3480145,[],CHEMBL1267756,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC,ug ml-1,UO_0000274,,0.06
95446,95446,,,3480146,[],CHEMBL1267756,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95447,95447,,,3480147,[],CHEMBL1267756,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95448,95448,,,3480148,[],CHEMBL1267755,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC,ug ml-1,UO_0000274,,0.06
95449,95449,,,3480149,[],CHEMBL1267755,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95450,95450,,,3480150,[],CHEMBL1267755,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95451,95451,,,3480151,[],CHEMBL1267754,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.06
95452,95452,,,3480152,[],CHEMBL1267754,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95453,95453,,,3480153,[],CHEMBL1267754,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95454,95454,,,3480154,[],CHEMBL1267753,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,0.06
95455,95455,,,3480155,[],CHEMBL1267753,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95456,95456,,,3480156,[],CHEMBL1267753,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95457,95457,,,3480157,[],CHEMBL1267752,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.06
95458,95458,,,3480158,[],CHEMBL1267752,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95459,95459,,,3480159,[],CHEMBL1267752,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95460,95460,,,3480160,[],CHEMBL1267751,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
95461,95461,,,3480161,[],CHEMBL1267751,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95462,95462,,,3480162,[],CHEMBL1267751,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95463,95463,,,3480163,[],CHEMBL1267750,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,,MIC,ug ml-1,UO_0000274,,0.06
95464,95464,,,3480164,[],CHEMBL1267750,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95465,95465,,,3480165,[],CHEMBL1267750,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus cohnii clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL615097,Staphylococcus cohnii,Staphylococcus cohnii,29382.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95466,95466,,,3480166,[],CHEMBL1267749,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC,ug ml-1,UO_0000274,,0.06
95467,95467,,,3480167,[],CHEMBL1267749,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95468,95468,,,3480168,[],CHEMBL1267749,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95469,95469,,,3480169,[],CHEMBL1267748,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
95470,95470,,,3480170,[],CHEMBL1267748,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95471,95471,,,3480171,[],CHEMBL1267748,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95472,95472,,,3480172,[],CHEMBL1267747,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
95473,95473,,,3480173,[],CHEMBL1267747,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95474,95474,,,3480174,[],CHEMBL1267747,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95475,95475,,,3480175,[],CHEMBL1267746,Antibacterial activity against vancomycin-susceptible Enterococcus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,<=,1,1,<=,,MIC90,ug.mL-1,,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,4.0
95476,95476,,,3480176,[],CHEMBL1267745,Antibacterial activity against vancomycin-resistant Enterococcus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,ug ml-1,UO_0000274,,1.0
95477,95477,,,3480283,[],CHEMBL1267744,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,958671,=,1,1,=,,MIC50,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,uM,UO_0000065,,2.0
95478,95478,,,3480485,[],CHEMBL1267758,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus xylosus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255376,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958671,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL2366870,Staphylococcus xylosus,Staphylococcus xylosus,1288.0,,,MIC,ug ml-1,UO_0000274,,0.06
95479,95479,,,3497338,[],CHEMBL1261266,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates by CLSi method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958365,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95480,95480,,,3497347,[],CHEMBL1261267,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,958365,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
95481,95481,,Not Active,3497356,[],CHEMBL1261268,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,958365,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95482,95482,,,3497365,[],CHEMBL1261269,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,958365,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
95483,95483,,Not Active,3497374,[],CHEMBL1261270,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,958365,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95484,95484,,,3497383,[],CHEMBL1261266,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates by CLSi method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958365,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95485,95485,,,3497392,[],CHEMBL1261272,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates by CLSi method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958365,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95486,95486,,,3497393,[],CHEMBL1261272,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates by CLSi method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958365,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95487,95487,,,3497410,[],CHEMBL1261273,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,958365,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
95488,95488,,Not Active,3497419,[],CHEMBL1261274,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by CLSI method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,958365,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95489,95489,,,3497428,[],CHEMBL1261275,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as susceptible isolates by EUCAST method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,958365,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
95490,95490,,Not Active,3497437,[],CHEMBL1261276,Antibacterial activity against methicillin-susceptible Staphylococcus aureus clinical isolates assessed as resistant isolates by EUCAST method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,958365,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95491,95491,,,3497446,[],CHEMBL1261271,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolates assessed as susceptibility breakpoint,F,,,BAO_0000181,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1255493,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,958365,<=,1,0,<=,,Activity,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,ug ml-1,UO_0000274,,1.0
95492,95492,,,3564262,[],CHEMBL1279790,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.12 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95493,95493,,,3564263,[],CHEMBL1279789,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 2 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,1.8
95494,95494,,,3564264,[],CHEMBL1279788,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 2 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.0
95495,95495,,,3564265,[],CHEMBL1279787,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 2 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95496,95496,,,3564266,[],CHEMBL1279653,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 2 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95497,95497,,,3564267,[],CHEMBL1279652,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 8 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,1.2
95498,95498,,,3564268,[],CHEMBL1279651,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 8 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,1.7
95499,95499,,,3564269,[],CHEMBL1279650,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 8 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,2.6
95500,95500,,,3564270,[],CHEMBL1279649,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 8 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95501,95501,,,3564271,[],CHEMBL1279648,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.12 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.0
95502,95502,,,3564272,[],CHEMBL1279647,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.12 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,0.8
95503,95503,,,3564273,[],CHEMBL1279646,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.12 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.3,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,2.3
95504,95504,,,3564274,[],CHEMBL1279645,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.12 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,0.6
95505,95505,,,3564275,[],CHEMBL1279644,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.25 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.0
95506,95506,,,3564276,[],CHEMBL1279643,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.25 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.9,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,0.9
95507,95507,,,3564277,[],CHEMBL1279642,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.25 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.6
95508,95508,,,3564278,[],CHEMBL1279641,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.25 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,3.6
95509,95509,,,3564279,[],CHEMBL1279640,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.5 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.87,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,0.87
95510,95510,,,3564280,[],CHEMBL1279639,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.5 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.0
95511,95511,,,3564281,[],CHEMBL1279638,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.5 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.6
95512,95512,,,3564282,[],CHEMBL1279637,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 0.5 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,3.6
95513,95513,,,3564283,[],CHEMBL1279636,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 2 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,0.8
95514,95514,,,3564284,[],CHEMBL1279635,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 2 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,0.8
95515,95515,,,3564285,[],CHEMBL1279634,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 2 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.0
95516,95516,,,3564286,[],CHEMBL1279633,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 2 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,2.7
95517,95517,,,3564287,[],CHEMBL1279632,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 8 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.1,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.1
95518,95518,,,3564288,[],CHEMBL1279631,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 8 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.9,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,0.9
95519,95519,,,3564289,[],CHEMBL1279630,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 8 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,1.8
95520,95520,,,3564290,[],CHEMBL1279629,Antibacterial activity against Streptococcus agalactiae MED 2038 assessed as bacterial count at 8 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,log10CFU/ml,,,,3.7
95521,95521,,,3564291,[],CHEMBL1279628,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.12 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,0.4
95522,95522,,,3564292,[],CHEMBL1279627,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.12 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,0.4
95523,95523,,,3564293,[],CHEMBL1279626,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.12 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,0.5
95524,95524,,,3564294,[],CHEMBL1279257,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.12 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,2.2
95525,95525,,,3564295,[],CHEMBL1279258,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.25 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,0.7
95526,95526,,,3564296,[],CHEMBL1279259,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.25 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,1.8
95527,95527,,,3564297,[],CHEMBL1279260,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.25 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,2.5
95528,95528,,,3564298,[],CHEMBL1279261,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.25 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,2.2
95529,95529,,,3564299,[],CHEMBL1279262,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.5 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.9,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,0.9
95530,95530,,,3564300,[],CHEMBL1279300,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.5 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,1.6
95531,95531,,,3564301,[],CHEMBL1279301,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.5 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.3,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,2.3
95532,95532,,,3564302,[],CHEMBL1279302,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 0.5 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,3.1
95533,95533,,,3564303,[],CHEMBL1279303,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 2 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,1.8
95534,95534,,,3564304,[],CHEMBL1279304,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 2 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,2.7
95535,95535,,,3564305,[],CHEMBL1279305,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 2 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,3.1
95536,95536,,,3564306,[],CHEMBL1279306,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 2 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,3.1
95537,95537,,,3564307,[],CHEMBL1279307,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 8 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,0.6
95538,95538,,,3564308,[],CHEMBL1279308,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 8 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,1.2
95539,95539,,,3564309,[],CHEMBL1279309,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 8 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,2.7
95540,95540,,,3564310,[],CHEMBL1279310,Antibacterial activity against Streptococcus pyogenes MED 2040 assessed as bacterial count at 8 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,log10CFU/ml,,,,2.7
95541,95541,,,3564311,[],CHEMBL1279311,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 2 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.5
95542,95542,,,3564312,[],CHEMBL1279312,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 2 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.5
95543,95543,,,3564313,[],CHEMBL1279313,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 2 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.6
95544,95544,,,3564314,[],CHEMBL1279314,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 2 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.8
95545,95545,,,3564315,[],CHEMBL1279315,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 4 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.5
95546,95546,,,3564316,[],CHEMBL1279316,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 4 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.5
95547,95547,,,3564317,[],CHEMBL1279317,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 4 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.7
95548,95548,,,3564318,[],CHEMBL1279318,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 4 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,1.2
95549,95549,,,3564319,[],CHEMBL1279319,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 8 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.2
95550,95550,,,3564320,[],CHEMBL1279320,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 8 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.2
95551,95551,,,3564321,[],CHEMBL1279321,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 8 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,0.5
95552,95552,,,3564322,[],CHEMBL1279322,Antibacterial activity against Enterococcus faecalis ATCC 51575 assessed as bacterial count at 8 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,log10CFU/ml,,,,1.0
95553,95553,,,3569994,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '750.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '750.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1281657,AUC (0 to infinity) in human epithelial lining fluid at 750 mg administered as single dose,A,,,BAO_0002120,BAO_0000221,tissue-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275431,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968331,=,1,1,=,,AUC,ng.hr.mL-1,,74750.0,CHEMBL612558,,ADMET,,,,AUC,mg.hr/L,,,74.75
95554,95554,,,3569995,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '750.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '750.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1281656,fAUC (0 to infinity) in human plasma at 750 mg administered as single dose,A,,,BAO_0002120,BAO_0000366,cell-free format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275431,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968331,=,1,1,=,,AUC,ng.hr.mL-1,,74040.0,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,AUC,mg.hr/L,,,74.04
95555,95555,,,3569996,[],CHEMBL1281658,"Penetration ratio, ratio of AUC in human epithelial lining fluid to fAUC in human plasma at 750 mg administered as single dose",A,,,BAO_0000193,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275431,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968331,=,1,0,=,,Ratio,,,1.01,CHEMBL612558,,ADMET,,,,Ratio,,,,1.01
95556,95556,,,3569997,[],CHEMBL1281655,Plasma protein binding in human plasma at 750 mg administered as single dose,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275431,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,968331,=,1,1,=,,PPB,%,,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,PPB,%,UO_0000187,,90.0
95557,95557,,,3572109,[],CHEMBL1278991,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate assessed as susceptibility level by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,968403,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
95558,95558,,,3572128,[],CHEMBL1278992,Antibacterial activity against vancomycin resistant Enterococcus faecium VanB clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,2.0
95559,95559,,,3572129,[],CHEMBL1278992,Antibacterial activity against vancomycin resistant Enterococcus faecium VanB clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95560,95560,,,3572130,[],CHEMBL1278992,Antibacterial activity against vancomycin resistant Enterococcus faecium VanB clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.06
95561,95561,,,3572149,[],CHEMBL1278993,Antibacterial activity against vancomycin resistant Enterococcus faecium VanA clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
95562,95562,,,3572150,[],CHEMBL1278993,Antibacterial activity against vancomycin resistant Enterococcus faecium VanA clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,8.0
95563,95563,,,3572151,[],CHEMBL1278993,Antibacterial activity against vancomycin resistant Enterococcus faecium VanA clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
95564,95564,,Not Active,3572524,[],CHEMBL1278994,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanB clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC50,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,,,,
95565,95565,,Not Active,3572525,[],CHEMBL1278994,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanB clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC90,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,,,,
95566,95566,,,3572526,[],CHEMBL1278994,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanB clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
95567,95567,,,3572542,[],CHEMBL1278995,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanA clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
95568,95568,,,3572543,[],CHEMBL1278995,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanA clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,8.0
95569,95569,,,3572544,[],CHEMBL1278995,Antibacterial activity against vancomycin resistant Enterococcus faecalis VanA clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
95570,95570,,Not Active,3572578,[],CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC90,,,,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,,,,
95571,95571,,Not Active,3572579,[],CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC50,,,,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,,,,
95572,95572,,,3572580,[],CHEMBL1278996,Antibacterial activity against Streptococcus viridans clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,ug ml-1,UO_0000274,,0.015
95573,95573,,Not Active,3572614,[],CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC90,,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC90,,,,
95574,95574,,Not Active,3572615,[],CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC50,,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC50,,,,
95575,95575,,,3572616,[],CHEMBL1278997,Antibacterial activity against Streptococcus constellatus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC,ug ml-1,UO_0000274,,0.015
95576,95576,,Not Active,3572650,[],CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC50,,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC50,,,,
95577,95577,,Not Active,3572651,[],CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC90,,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC90,,,,
95578,95578,,,3572654,[],CHEMBL1278998,Antibacterial activity against Streptococcus oralis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,0.015
95579,95579,,Not Active,3572684,[],CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC50,,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC50,,,,
95580,95580,,Not Active,3572685,[],CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC90,,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC90,,,,
95581,95581,,,3572688,[],CHEMBL1278999,Antibacterial activity against Streptococcus intermedius clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC,ug ml-1,UO_0000274,,0.015
95582,95582,,Not Active,3572722,[],CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC90,,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC90,,,,
95583,95583,,Not Active,3572723,[],CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,,1,0,,,MIC50,,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC50,,,,
95584,95584,,,3572724,[],CHEMBL1279000,Antibacterial activity against Streptococcus mitis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.015
95585,95585,,,3572758,[],CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.06
95586,95586,,,3572759,[],CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.06
95587,95587,,,3572760,[],CHEMBL1279001,Antibacterial activity against Streptococcus agalactiae group B clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.03
95588,95588,,,3572794,[],CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.06
95589,95589,,,3572795,[],CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.03
95590,95590,,,3572796,[],CHEMBL1279002,Antibacterial activity against Streptococcus pyogenes group A clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,<=,1,1,<=,,MIC,ug.mL-1,,0.001,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.001
95591,95591,,,3572830,[],CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
95592,95592,,,3572831,[],CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.015
95593,95593,,,3572832,[],CHEMBL1279003,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.03
95594,95594,,,3573216,[],CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
95595,95595,,,3573217,[],CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.015
95596,95596,,,3573218,[],CHEMBL1279004,Antibacterial activity against penicillin resistant Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.03
95597,95597,,,3573252,[],CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.004
95598,95598,,,3573253,[],CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.015
95599,95599,,,3573254,[],CHEMBL1279005,Antibacterial activity against penicillin intermediate Streptococcus pneumoniae clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.06
95600,95600,,,3573279,[],CHEMBL1279006,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.06
95601,95601,,,3573280,[],CHEMBL1279006,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95602,95602,,,3573281,[],CHEMBL1279006,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus saprophyticus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,1.0
95603,95603,,,3573306,[],CHEMBL1279007,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
95604,95604,,,3573307,[],CHEMBL1279007,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
95605,95605,,,3573308,[],CHEMBL1279007,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus hominis subsp. novobiosepticus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
95606,95606,,,3573333,[],CHEMBL1279008,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.06
95607,95607,,,3573334,[],CHEMBL1279008,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95608,95608,,,3573335,[],CHEMBL1279008,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus haemolyticus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,1.0
95609,95609,,,3573360,[],CHEMBL1279009,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC,ug ml-1,UO_0000274,,0.06
95610,95610,,,3573361,[],CHEMBL1279009,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95611,95611,,,3573362,[],CHEMBL1279009,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus capitis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612681,Staphylococcus capitis,Staphylococcus capitis,29388.0,,,MIC90,ug ml-1,UO_0000274,,1.0
95612,95612,,,3573387,[],CHEMBL1279010,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
95613,95613,,,3573388,[],CHEMBL1279010,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
95614,95614,,,3573389,[],CHEMBL1279010,Antibacterial activity against methicillin resistant coagulase-negative Staphylococcus auricularis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
95615,95615,,,3573414,[],CHEMBL1279011,Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
95616,95616,,,3573415,[],CHEMBL1279011,Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.5
95617,95617,,,3573416,[],CHEMBL1279011,Antibacterial activity against methicillin resistant Staphylococcus epidermidis clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,1.0
95618,95618,,,3573449,[],CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
95619,95619,,,3573450,[],CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95620,95620,,,3573451,[],CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
95621,95621,,,3573452,[],CHEMBL1279012,Antibacterial activity against methicillin resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,968403,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
95622,95622,,,3573468,[],CHEMBL1278924,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95623,95623,,,3573471,[],CHEMBL1278923,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95624,95624,,,3573474,[],CHEMBL1278922,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
95625,95625,,,3573477,[],CHEMBL1278921,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
95626,95626,,,3573480,[],CHEMBL1278920,Antibacterial activity against Streptococcus agalactiae MED 2038 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.06
95627,95627,,,3573483,[],CHEMBL1278918,Antibacterial activity against Streptococcus pyogenes MED 2040 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
95628,95628,,,3573486,[],CHEMBL1278919,Antibacterial activity against Enterococcus faecalis ATCC 51575 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,968403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
95629,95629,,,3573488,[],CHEMBL1278917,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 1 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.7
95630,95630,,,3573489,[],CHEMBL1278916,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 1 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.3
95631,95631,,,3573490,[],CHEMBL1278915,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 1 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.4
95632,95632,,,3573491,[],CHEMBL1278914,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 1 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.1
95633,95633,,,3573492,[],CHEMBL1278913,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 2 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.6
95634,95634,,,3573493,[],CHEMBL1278912,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 2 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.6
95635,95635,,,3573494,[],CHEMBL1278911,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 2 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.1
95636,95636,,,3573495,[],CHEMBL1278910,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 2 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.4
95637,95637,,,3573496,[],CHEMBL1278909,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 4 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.7
95638,95638,,,3573497,[],CHEMBL1278908,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 4 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.7
95639,95639,,,3573498,[],CHEMBL1280202,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 4 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.4
95640,95640,,,3573499,[],CHEMBL1280201,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 4 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.4
95641,95641,,,3573500,[],CHEMBL1280200,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 8 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.4
95642,95642,,,3573501,[],CHEMBL1280199,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 8 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.2
95643,95643,,,3573502,[],CHEMBL1280198,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 8 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.4
95644,95644,,,3573503,[],CHEMBL1280197,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 8 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.4
95645,95645,,,3573504,[],CHEMBL1280196,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 16 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.3
95646,95646,,,3573505,[],CHEMBL1280195,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 16 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.8
95647,95647,,,3573506,[],CHEMBL1280194,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 16 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.3
95648,95648,,,3573507,[],CHEMBL1280193,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 2028 osteomyelitis isolate assessed as bacterial count at 16 ug/ml after 24 hr by time-kill assay ,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.4
95649,95649,,,3573508,[],CHEMBL1280192,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 1 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.9
95650,95650,,,3573509,[],CHEMBL1280191,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 1 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.8
95651,95651,,,3573510,[],CHEMBL1280190,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 1 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.2
95652,95652,,,3573511,[],CHEMBL1280189,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 1 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.7
95653,95653,,,3573512,[],CHEMBL1280188,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 2 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.0
95654,95654,,,3573513,[],CHEMBL1280187,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 2 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.8
95655,95655,,,3573514,[],CHEMBL1280186,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 2 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.7
95656,95656,,,3573515,[],CHEMBL1280185,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 2 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.8
95657,95657,,,3573516,[],CHEMBL1280184,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 4 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.2
95658,95658,,,3573517,[],CHEMBL1280183,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 4 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.8
95659,95659,,,3573518,[],CHEMBL1280182,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 4 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.0
95660,95660,,,3573519,[],CHEMBL1280181,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 4 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.3
95661,95661,,,3573520,[],CHEMBL1280180,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 16 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,0.7
95662,95662,,,3573521,[],CHEMBL1280179,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 16 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,1.6
95663,95663,,,3573522,[],CHEMBL1280178,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 16 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,2.9
95664,95664,,,3573523,[],CHEMBL1280049,Antibacterial activity against methicillin resistant Staphylococcus aureus MED 1805 bloodstream isolate assessed as bacterial count at 16 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.3
95665,95665,,,3573524,[],CHEMBL1280048,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 2 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,0.2
95666,95666,,,3573525,[],CHEMBL1280047,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 2 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,0.03
95667,95667,,,3573526,[],CHEMBL1280046,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 2 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,0.7
95668,95668,,,3573527,[],CHEMBL1280045,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 2 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.1
95669,95669,,,3573528,[],CHEMBL1280044,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 4 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,1.0
95670,95670,,,3573529,[],CHEMBL1280043,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 4 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,1.8
95671,95671,,,3573530,[],CHEMBL1280042,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 4 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.2
95672,95672,,,3573531,[],CHEMBL1280041,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 4 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.3
95673,95673,,,3573532,[],CHEMBL1280040,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 8 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,0.5
95674,95674,,,3573533,[],CHEMBL1280039,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 8 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,2.7
95675,95675,,,3573534,[],CHEMBL1280038,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 8 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.3
95676,95676,,,3573535,[],CHEMBL1280037,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 8 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.3
95677,95677,,,3573536,[],CHEMBL1280036,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 16 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,0.5
95678,95678,,,3573537,[],CHEMBL1280035,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 16 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.2
95679,95679,,,3573538,[],CHEMBL1280034,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 16 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.3
95680,95680,,,3573539,[],CHEMBL1280033,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 35984 assessed as bacterial count at 16 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10CFU/ml,,,,3.3
95681,95681,,,3573540,[],CHEMBL1280032,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.03 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,1.1
95682,95682,,,3573541,[],CHEMBL1280031,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.03 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,2.7
95683,95683,,,3573542,[],CHEMBL1280030,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.03 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95684,95684,,,3573543,[],CHEMBL1280029,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.03 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95685,95685,,,3573544,[],CHEMBL1280028,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.06 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,1.0
95686,95686,,,3573545,[],CHEMBL1280027,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.06 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,2.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,2.1
95687,95687,,,3573546,[],CHEMBL1280026,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.06 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95688,95688,,,3573547,[],CHEMBL1280025,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.06 ug/ml after 24 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.4
95689,95689,,,3573548,[],CHEMBL1280024,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.12 ug/ml after 2 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,1.1
95690,95690,,,3573549,[],CHEMBL1279792,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.12 ug/ml after 4 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,1.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,1.9
95691,95691,,,3573550,[],CHEMBL1279791,Antibacterial activity against multidrug resistant Streptococcus pneumoniae MED 1090 assessed as bacterial count at 0.12 ug/ml after 8 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1275440,Antimicrob Agents Chemother,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,968403,=,1,0,=,,log10CFU/ml,,,3.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,log10CFU/ml,,,,3.3
95692,95692,,,5079604,[],CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1310407,=,1,1,=,,Vdss,L.kg-1,,0.11,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,0.11
95693,95693,,,5079813,[],CHEMBL1614671,Clearance in human after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1310407,=,1,1,=,,CL,mL.min-1.kg-1,,0.2,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,0.2
95694,95694,,,5080017,[],CHEMBL1614672,Fraction unbound in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1310407,=,1,1,=,,Fu,,,0.07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fu,,,,0.07
95695,95695,,,5082579,[],CHEMBL1614674,Half life in human after iv administration,A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1310407,=,1,1,=,,T1/2,hr,,6.7,CHEMBL612558,,ADMET,,,,t1/2,h,UO_0000032,,6.7
95696,95696,,,5082818,[],CHEMBL1614673,Mean residence time in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1310407,=,1,1,=,,MRT,hr,,9.2,CHEMBL612558,,ADMET,,,,MRT,h,UO_0000032,,9.2
95697,95697,,,5103790,[],CHEMBL1638585,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95698,95698,,,5103791,[],CHEMBL1638586,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
95699,95699,,,5103792,[],CHEMBL1638587,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
95700,95700,,,5103793,[],CHEMBL1638588,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
95701,95701,,,5103794,[],CHEMBL1638589,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
95702,95702,,,5103795,[],CHEMBL1638590,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
95703,95703,,,5103796,[],CHEMBL1638591,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95704,95704,,,5103797,[],CHEMBL1639384,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95705,95705,,,5103798,[],CHEMBL1639385,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95706,95706,,,5103799,[],CHEMBL1639386,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95707,95707,,,5103800,[],CHEMBL1639387,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 by microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95708,95708,,,5103801,[],CHEMBL1639519,Antimicrobial activity against Streptococcus pyogenes HMC 414 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
95709,95709,,,5103802,[],CHEMBL1639520,Antimicrobial activity against Streptococcus agalactiae HMC 5 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.12
95710,95710,,,5103803,[],CHEMBL1639521,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
95711,95711,,,5103804,[],CHEMBL1639522,Antimicrobial activity against Enterococcus faecalis HMC 571 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
95712,95712,,,5103805,[],CHEMBL1639523,Antimicrobial activity against Enterococcus faecium HMC 588 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313041,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.12
95713,95713,,,5103806,[],CHEMBL1639524,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.5
95714,95714,,,5103807,[],CHEMBL1639525,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.4
95715,95715,,,5103808,[],CHEMBL1639526,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.1
95716,95716,,,5103809,[],CHEMBL1639527,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.8
95717,95717,,,5103810,[],CHEMBL1639528,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.2
95718,95718,,,5103811,[],CHEMBL1639529,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.7
95719,95719,,,5103812,[],CHEMBL1639530,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,3.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,3.4
95720,95720,,,5103813,[],CHEMBL1639531,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.6
95721,95721,,,5103814,[],CHEMBL1639532,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.2
95722,95722,,,5103815,[],CHEMBL1639533,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.9
95723,95723,,,5103816,[],CHEMBL1639534,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as post-antibiotic effect at 10 times MIC pre-exposed for 1 hr by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.3
95724,95724,,,5103817,[],CHEMBL1639535,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PAE,hr,UO_0000032,,6.1
95725,95725,,,5103818,[],CHEMBL1639536,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.4,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,PAE,hr,UO_0000032,,0.4
95726,95726,,,5103819,[],CHEMBL1639537,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.3,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,0.3
95727,95727,,,5103820,[],CHEMBL1639538,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,1.5
95728,95728,,,5103821,[],CHEMBL1639539,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as post-antibiotic effect at 10 times MIC pre-exposed to Telavancin for 1 hr by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,PAE,hr,UO_0000032,,1.2
95729,95729,,,5103822,[],CHEMBL1639540,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.3
95730,95730,,,5103823,[],CHEMBL1639541,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.0
95731,95731,,,5103824,[],CHEMBL1639542,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.0
95732,95732,,,5103825,[],CHEMBL1639543,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.7
95733,95733,,,5103826,[],CHEMBL1639544,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.0
95734,95734,,,5103827,[],CHEMBL1639545,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.3
95735,95735,,,5103828,[],CHEMBL1639546,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.3
95736,95736,,,5103829,[],CHEMBL1639547,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.7
95737,95737,,,5103830,[],CHEMBL1639548,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.0
95738,95738,,,5103831,[],CHEMBL1639549,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.0
95739,95739,,,5103832,[],CHEMBL1639550,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.9
95740,95740,,,5103833,[],CHEMBL1639676,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PAE,hr,UO_0000032,,0.0
95741,95741,,,5103834,[],CHEMBL1639677,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.2,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,PAE,hr,UO_0000032,,0.2
95742,95742,,,5103835,[],CHEMBL1639678,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,0.7
95743,95743,,,5103836,[],CHEMBL1639679,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.1,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,0.1
95744,95744,,,5103837,[],CHEMBL1639680,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,PAE,hr,UO_0000032,,1.2
95745,95745,,,5103838,[],CHEMBL1639681,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,7.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,7.7
95746,95746,,,5103839,[],CHEMBL1639682,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.4
95747,95747,,,5103840,[],CHEMBL1639683,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.0
95748,95748,,,5103841,[],CHEMBL1639684,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.9
95749,95749,,,5103842,[],CHEMBL1639685,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.7
95750,95750,,,5103843,[],CHEMBL1639686,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.7
95751,95751,,,5103844,[],CHEMBL1639687,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.9
95752,95752,,,5103845,[],CHEMBL1639688,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,3.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,3.8
95753,95753,,,5103846,[],CHEMBL1640444,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.1
95754,95754,,,5103847,[],CHEMBL1640445,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.8
95755,95755,,,5103848,[],CHEMBL1640446,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.6
95756,95756,,,5103849,[],CHEMBL1640447,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,8.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PAE,hr,UO_0000032,,8.7
95757,95757,,,5103850,[],CHEMBL1640448,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,PAE,hr,UO_0000032,,0.8
95758,95758,,,5103851,[],CHEMBL1640449,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.3,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,5.3
95759,95759,,,5103852,[],CHEMBL1640563,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,3.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,3.9
95760,95760,,,5103853,[],CHEMBL1640564,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce post antibiotic sub-MIC effect at 0.2 times MIC pre-exposed to Telavancin for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,PAE,hr,UO_0000032,,1.9
95761,95761,,,5103854,[],CHEMBL1640565,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.4
95762,95762,,,5103855,[],CHEMBL1640566,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.0
95763,95763,,,5103856,[],CHEMBL1640567,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.6
95764,95764,,,5103857,[],CHEMBL1640568,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.1
95765,95765,,,5103858,[],CHEMBL1640569,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.5
95766,95766,,,5103859,[],CHEMBL1640570,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.5
95767,95767,,,5103860,[],CHEMBL1640571,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.7
95768,95768,,,5103861,[],CHEMBL1640572,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.8
95769,95769,,,5103862,[],CHEMBL1640573,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.4
95770,95770,,,5103863,[],CHEMBL1640574,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.6
95771,95771,,,5103864,[],CHEMBL1640575,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.3
95772,95772,,,5103865,[],CHEMBL1640576,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PAE,hr,UO_0000032,,0.0
95773,95773,,,5103866,[],CHEMBL1640577,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.1,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,PAE,hr,UO_0000032,,2.1
95774,95774,,,5103867,[],CHEMBL1640578,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,2.0
95775,95775,,,5103868,[],CHEMBL1640579,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,2.6
95776,95776,,,5103869,[],CHEMBL1640580,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,7.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,PAE,hr,UO_0000032,,7.2
95777,95777,,,5103870,[],CHEMBL1640581,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95778,95778,,,5103871,[],CHEMBL1640582,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95779,95779,,,5103872,[],CHEMBL1640583,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.5
95780,95780,,,5103873,[],CHEMBL1640584,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,5.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,5.4
95781,95781,,,5103874,[],CHEMBL1640585,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,8.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,8.3
95782,95782,,,5103875,[],CHEMBL1640586,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,8.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,8.3
95783,95783,,,5103876,[],CHEMBL1640587,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,4.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,4.8
95784,95784,,,5103877,[],CHEMBL1640588,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.3
95785,95785,,,5103878,[],CHEMBL1640589,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,8.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,8.6
95786,95786,,,5103879,[],CHEMBL1640590,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95787,95787,,,5103880,[],CHEMBL1640591,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.0
95788,95788,,,5103881,[],CHEMBL1640755,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PAE,hr,UO_0000032,,10.7
95789,95789,,,5103882,[],CHEMBL1640756,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,4.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,PAE,hr,UO_0000032,,4.7
95790,95790,,,5103883,[],CHEMBL1640757,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,10.7
95791,95791,,,5103884,[],CHEMBL1640758,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,7.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,7.2
95792,95792,,,5103885,[],CHEMBL1640759,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce post antibiotic sub-MIC effect at 0.3 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,8.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,PAE,hr,UO_0000032,,8.9
95793,95793,,,5103886,[],CHEMBL1640760,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.3
95794,95794,,,5103887,[],CHEMBL1640761,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.5
95795,95795,,,5103888,[],CHEMBL1640762,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.3
95796,95796,,,5103889,[],CHEMBL1640763,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.0
95797,95797,,,5103890,[],CHEMBL1640764,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,1.0
95798,95798,,,5103891,[],CHEMBL1638642,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,2.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,2.3
95799,95799,,,5103892,[],CHEMBL1638643,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,4.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,4.3
95800,95800,,,5103893,[],CHEMBL1638644,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.8
95801,95801,,,5103894,[],CHEMBL1638645,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,0.8
95802,95802,,,5103895,[],CHEMBL1638646,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95803,95803,,,5103896,[],CHEMBL1638647,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,3.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,3.6
95804,95804,,,5103897,[],CHEMBL1638648,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,0.4,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PAE,hr,UO_0000032,,0.4
95805,95805,,,5103898,[],CHEMBL1638649,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,PAE,hr,UO_0000032,,10.7
95806,95806,,,5103899,[],CHEMBL1638783,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,3.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,3.6
95807,95807,,,5103900,[],CHEMBL1638784,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,9.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,9.6
95808,95808,,,5103901,[],CHEMBL1638785,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,8.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,PAE,hr,UO_0000032,,8.8
95809,95809,,,5103902,[],CHEMBL1638786,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95810,95810,,,5103903,[],CHEMBL1638787,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1130 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95811,95811,,,5103904,[],CHEMBL1638788,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1307 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.5
95812,95812,,,5103905,[],CHEMBL1638789,"Antimicrobial activity against vancomycin-susceptible-, methicillin-resistant Staphylococcus aureus 1306 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.6
95813,95813,,,5103906,[],CHEMBL1638790,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 873 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,6.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,6.7
95814,95814,,,5103907,[],CHEMBL1638791,"Antimicrobial activity against heterogenous vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 618 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.3
95815,95815,,,5103908,[],CHEMBL1638792,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 555 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.3
95816,95816,,,5103909,[],CHEMBL1638793,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 770 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,9.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,9.6
95817,95817,,,5103910,[],CHEMBL1638794,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1287 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95818,95818,,,5103911,[],CHEMBL1638795,"Antimicrobial activity against vancomycin-intermediate-, methicillin-resistant Staphylococcus aureus 1984 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,10.0
95819,95819,,,5103912,[],CHEMBL1638796,"Antimicrobial activity against vancomycin-resistant-, methicillin-resistant Staphylococcus aureus 510 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,8.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,PAE,hr,UO_0000032,,8.1
95820,95820,,,5103913,[],CHEMBL1638797,Antimicrobial activity against Streptococcus pyogenes HMC 414 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.7,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,PAE,hr,UO_0000032,,10.7
95821,95821,,,5103914,[],CHEMBL1638798,Antimicrobial activity against Streptococcus agalactiae HMC 5 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.7,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,PAE,hr,UO_0000032,,10.7
95822,95822,,,5103915,[],CHEMBL1638799,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.7,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,10.7
95823,95823,,,5103916,[],CHEMBL1638800,Antimicrobial activity against Enterococcus faecalis HMC 571 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,PAE,hr,UO_0000032,,10.6
95824,95824,,,5103917,[],CHEMBL1638801,Antimicrobial activity against Enterococcus faecium HMC 588 assessed as time required to induce post antibiotic sub-MIC effect at 0.4 times MIC exposed for 2 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,=,1,0,=,,PAE,hr,,10.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,PAE,hr,UO_0000032,,10.0
95825,95825,,,5103918,[],CHEMBL1638802,"Elimination half life in healthy human at 5 mg/kg, iv",A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1313041,>,1,1,>,,T1/2,hr,,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,beta t1/2,hr,UO_0000032,,7.0
95826,95826,,,5103919,[],CHEMBL1638803,Protein binding healthy human serum,A,,,BAO_0000179,BAO_0000366,cell-free format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1629663,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1313041,>=,1,1,>=,,PPB,%,,90.0,CHEMBL613426,Homo sapiens,Serum,9606.0,,,PB,%,UO_0000187,,90.0
95827,95827,,,5150717,[],CHEMBL1664925,Antimicrobial activity against Staphylococcus aureus P1 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326717,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95828,95828,,,5150718,[],CHEMBL1664925,Antimicrobial activity against Staphylococcus aureus P1 by macrodilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326717,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
95829,95829,,,5150723,[],CHEMBL1664922,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter bacterial colonization rate at 15 mg/kg, iv (Rvb = 100%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,,Activity,%,,39.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,39.0
95830,95830,,,5150724,[],CHEMBL1664918,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter related infection rate at 15 mg/kg, iv (Rvb = 100%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,,Activity,%,,35.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,35.0
95831,95831,,,5150725,[],CHEMBL1664921,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter bacterial colonization rate at 30 mg/kg, iv (Rvb = 100%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,,Activity,%,,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,11.0
95832,95832,,,5150726,[],CHEMBL1664917,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter related infection rate at 30 mg/kg, iv (Rvb = 100%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,,Activity,%,,9.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,9.0
95833,95833,,,5150727,[],CHEMBL1664920,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter bacterial colonization rate at 45 mg/kg, iv (Rvb = 100%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,,Activity,%,,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,11.0
95834,95834,,,5150728,[],CHEMBL1664924,"Antimicrobial activity against Staphylococcus aureus P1 infected in New Zealand rabbit assessed as decrease in catheter related infection rate at 45 mg/kg, iv (Rvb = 100%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649486,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1326717,=,1,0,=,,Activity,%,,11.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,11.0
95835,95835,,,5163081,[],CHEMBL1665289,Antibacterial activity against slime-negative Staphylococcus epidermidis M7 after 24 hrs by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
95836,95836,,,5163082,[],CHEMBL1665290,Antibacterial activity against slime-negative Staphylococcus epidermidis M7 assessed as inhibition of biofilm formation after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBIC,ug ml-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBIC,ug ml-1,UO_0000274,,0.5
95837,95837,,,5163083,[],CHEMBL1665291,Antibacterial activity against slime-negative Staphylococcus epidermidis M7 assessed as induction of biofilm eradication after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBEC,ug ml-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBEC,ug ml-1,UO_0000274,,0.5
95838,95838,,,5163084,[],CHEMBL1665292,Antibacterial activity against Staphylococcus epidermidis RP62A after 24 hrs by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
95839,95839,,,5163085,[],CHEMBL1665293,Antibacterial activity against Staphylococcus epidermidis RP62A assessed as inhibition of biofilm formation after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBIC,ug ml-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBIC,ug ml-1,UO_0000274,,0.5
95840,95840,,,5163086,[],CHEMBL1665294,Antibacterial activity against Staphylococcus epidermidis RP62A assessed as induction of biofilm eradication after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBEC,ug ml-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBEC,ug ml-1,UO_0000274,,1.0
95841,95841,,,5163087,[],CHEMBL1665295,Antibacterial activity against Staphylococcus aureus ATCC 35556 after 24 hrs by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
95842,95842,,,5163088,[],CHEMBL1665296,Antibacterial activity against Staphylococcus aureus ATCC 35556 assessed as inhibition of biofilm formation after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBIC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,ug ml-1,UO_0000274,,0.25
95843,95843,,,5163089,[],CHEMBL1665297,Antibacterial activity against Staphylococcus aureus ATCC 35556 assessed as induction of biofilm eradication after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBEC,ug ml-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBEC,ug ml-1,UO_0000274,,0.125
95844,95844,,,5163090,[],CHEMBL1665298,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
95845,95845,,,5163091,[],CHEMBL1665299,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as inhibition of biofilm formation after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBIC,ug ml-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MBIC,ug ml-1,UO_0000274,,1.0
95846,95846,,,5163092,[],CHEMBL1665300,Antibacterial activity against Enterococcus faecalis ATCC 29212 assessed as induction of biofilm eradication after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBEC,ug ml-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MBEC,ug ml-1,UO_0000274,,1.0
95847,95847,,,5163093,[],CHEMBL1665301,Antibacterial activity against methicillin-susceptible Staphylococcus aureus L2 after 24 hrs by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
95848,95848,,,5163094,[],CHEMBL1665302,Antibacterial activity against methicillin-susceptible Staphylococcus aureus L2 assessed as inhibition of biofilm formation after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBIC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,ug ml-1,UO_0000274,,1.0
95849,95849,,,5163095,[],CHEMBL1665303,Antibacterial activity against methicillin-susceptible Staphylococcus aureus L2 assessed as induction of biofilm eradication after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBEC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBEC,ug ml-1,UO_0000274,,1.0
95850,95850,,,5163096,[],CHEMBL1665304,Antibacterial activity against methicillin-resistant Staphylococcus aureus L32 after 24 hrs by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
95851,95851,,,5163097,[],CHEMBL1665305,Antibacterial activity against methicillin-resistant Staphylococcus aureus L32 assessed as inhibition of biofilm formation after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBIC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,ug ml-1,UO_0000274,,1.0
95852,95852,,,5163098,[],CHEMBL1665306,Antibacterial activity against methicillin-resistant Staphylococcus aureus L32 assessed as induction of biofilm eradication after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBEC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBEC,ug ml-1,UO_0000274,,2.0
95853,95853,,,5163099,[],CHEMBL1665307,Antibacterial activity against methicillin-resistant Staphylococcus aureus L83 after 24 hrs by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
95854,95854,,,5163100,[],CHEMBL1665308,Antibacterial activity against methicillin-resistant Staphylococcus aureus L83 assessed as inhibition of biofilm formation after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBIC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,ug ml-1,UO_0000274,,0.25
95855,95855,,,5163101,[],CHEMBL1665309,Antibacterial activity against methicillin-resistant Staphylococcus aureus L83 assessed as induction of biofilm eradication after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBEC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBEC,ug ml-1,UO_0000274,,1.0
95856,95856,,,5163102,[],CHEMBL1665289,Antibacterial activity against slime-negative Staphylococcus epidermidis M7 after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,0.125
95857,95857,,,5163103,[],CHEMBL1665292,Antibacterial activity against Staphylococcus epidermidis RP62A after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,0.125
95858,95858,,,5163104,[],CHEMBL1665295,Antibacterial activity against Staphylococcus aureus ATCC 35556 after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
95859,95859,,,5163105,[],CHEMBL1665298,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MBC,ug ml-1,UO_0000274,,1.0
95860,95860,,,5163106,[],CHEMBL1665301,Antibacterial activity against methicillin-susceptible Staphylococcus aureus L2 after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.125
95861,95861,,,5163107,[],CHEMBL1665304,Antibacterial activity against methicillin-resistant Staphylococcus aureus L32 after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.125
95862,95862,,,5163108,[],CHEMBL1665307,Antibacterial activity against methicillin-resistant Staphylococcus aureus L83 after 24 hrs by CLSI method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.125
95863,95863,,,5163117,[],CHEMBL1665288,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649538,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327040,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
95864,95864,,,5163571,[],CHEMBL1666226,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 494 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95865,95865,,,5163572,[],CHEMBL1666362,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus 1199 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95866,95866,,,5163573,[],CHEMBL1666363,Antimicrobial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
95867,95867,,,5163574,[],CHEMBL1666364,Antimicrobial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95868,95868,,,5163587,[],CHEMBL1653105,Antibacterial activity against methicillin-resistant Staphylococcus aureus 494 assessed as bacterial load per gram in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 96 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,=,1,0,=,,CFU/g,,,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,CFU/g,,,,2.8
95869,95869,,,5163588,[],CHEMBL1653106,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 1199 assessed as bacterial load per gram in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 96 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,=,1,0,=,,CFU/g,,,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,CFU/g,,,,2.8
95870,95870,,,5163589,[],CHEMBL1653107,Antibacterial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 assessed as bacterial load per gram in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 96 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,=,1,0,=,,CFU/g,,,4.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,CFU/g,,,,4.2
95871,95871,,,5163590,[],CHEMBL1653108,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 assessed as bacterial load per gram in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 96 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,=,1,0,=,,CFU/g,,,4.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,CFU/g,,,,4.1
95872,95872,,Active,5163591,[],CHEMBL1653109,Antibacterial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 64 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95873,95873,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5163592,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}]",CHEMBL1666225,Cmax in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg for every 12 hrs,A,,,BAO_0002119,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/Nanomolar,1326814,=,1,1,=,,Cmax,nM,,50180.56,CHEMBL612558,,ADMET,,,,Cmax,ug ml-1,UO_0000065,,88.1
95874,95874,,,5163593,[],CHEMBL1653090,Cmin in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg for every 12 hrs,A,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326814,=,1,0,=,,Cmin,ug ml-1,,14.1,CHEMBL612558,,ADMET,,,,Cmin,ug ml-1,UO_0000274,,14.1
95875,95875,,,5163594,[],CHEMBL1653091,Half life in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg for every 12 hrs,A,,,BAO_0002115,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Hour,1326814,=,1,1,=,,T1/2,hr,,9.1,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,9.1
95876,95876,,,5163595,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1653092,AUC (0 to 24 hrs) in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg for every 12 hrs,A,,,BAO_0002120,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,=,1,1,=,,AUC,ng.hr.mL-1,,968800.0,CHEMBL612558,,ADMET,,,,AUC,ug/ml.hr,,,968.8
95877,95877,,Active,5163608,[],CHEMBL1653110,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 10 mg/kg administered daily after 62 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95878,95878,,Not Active,5163609,[],CHEMBL1653111,Antibacterial activity against methicillin-resistant Staphylococcus aureus 494 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95879,95879,,Not Active,5163610,[],CHEMBL1653112,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 1199 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95880,95880,,Not Active,5163611,[],CHEMBL1653113,Antibacterial activity against heteroresistant glycopeptide-intermediate Staphylococcus aureus 1629 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95881,95881,,Not Active,5163612,[],CHEMBL1653114,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus NJ992 assessed as decrease in bacterial load in in vitro pharmacokinetic/pharmacodynamic model at 1 g for every 12 hrs administered daily after 96 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649505,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1326814,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95882,95882,,,5181358,[],CHEMBL1667103,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
95883,95883,,,5181359,[],CHEMBL1667105,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,77.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,77.0
95884,95884,,,5181360,[],CHEMBL1667104,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization by flow cytometry,F,,,BAO_0000190,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,,IC50,ug.mL-1,,3.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,ug ml-1,UO_0000274,,3.6
95885,95885,,Dose-dependent effect,5181365,[],CHEMBL1667104,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization by flow cytometry,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1327105,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95886,95886,,,5181367,[],CHEMBL1667109,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus ATCC 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95887,95887,,,5181368,[],CHEMBL1667101,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95888,95888,,,5181369,[],CHEMBL1667110,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus ATCC 700698,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95889,95889,,,5181370,[],CHEMBL1667111,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus MED2034,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95890,95890,,,5181372,[],CHEMBL1667106,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus ATCC 700699 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,61.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,61.0
95891,95891,,,5181373,[],CHEMBL1667107,Antibacterial activity against heterogeneous vancomycin-intermediate Staphylococcus aureus ATCC 700698 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,78.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,78.0
95892,95892,,,5181374,[],CHEMBL1667108,Antibacterial activity against daptomycin-nonsusceptible Staphylococcus aureus MED2034 assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,77.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,77.0
95893,95893,,,5181375,[],CHEMBL1667112,Antibacterial activity against Staphylococcus aureus in presence of 0.05 mM D-Ala-D-Ala,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
95894,95894,,,5181376,[],CHEMBL1667113,Antibacterial activity against Staphylococcus aureus in presence of 0.5 mM D-Ala-D-Ala,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
95895,95895,,,5181377,[],CHEMBL1667114,Antibacterial activity against Staphylococcus aureus in presence of 5 mM D-Ala-D-Ala,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327105,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
95896,95896,,,5181378,[],CHEMBL1667102,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,49.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,49.0
95897,95897,,,5181379,[],CHEMBL1667098,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry in presence of 0.05 mM D-Ala-D-Ala,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,33.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,33.0
95898,95898,,,5181380,[],CHEMBL1667099,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry in presence of 0.5 mM D-Ala-D-Ala,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,17.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,17.0
95899,95899,,,5181381,[],CHEMBL1667100,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 8 ug/ml by flow cytometry in presence of 5 mM D-Ala-D-Ala,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,7.0
95900,95900,,,5181382,[],CHEMBL1667115,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,94.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,94.0
95901,95901,,,5181383,[],CHEMBL1667116,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry in presence of 0.05 mM D-Ala-D-Ala,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,68.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,68.0
95902,95902,,,5181384,[],CHEMBL1667117,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry in presence of 0.5 mM D-Ala-D-Ala,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,19.0
95903,95903,,,5181385,[],CHEMBL1667118,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial membrane depolarization at 32 ug/ml by flow cytometry in presence of 5 mM D-Ala-D-Ala,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,14.0
95904,95904,,,5181386,[],CHEMBL1667119,Inhibition of bacterial cell wall precursor lipid 2 synthesis in Staphylococcus aureus assessed as induction of membrane depolarization at 32 ug/ml by flow cytometry in presence of fosfomycin,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,29.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,29.0
95905,95905,,,5181387,[],CHEMBL1667120,Inhibition of bacterial cell wall precursor lipid 2 synthesis in Staphylococcus aureus assessed as induction of membrane depolarization at 32 ug/ml by flow cytometry in presence of D-cycloserine,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,38.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,38.0
95906,95906,,,5181388,[],CHEMBL1667121,Inhibition of bacterial cell wall precursor lipid 2 synthesis in Staphylococcus aureus assessed as induction of membrane depolarization at 32 ug/ml by flow cytometry in presence of bacitracin,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1327105,=,1,0,=,,Activity,%,,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,27.0
95907,95907,,Active,5181392,[],CHEMBL1667122,Antibacterial activity against Staphylococcus aureus grown in PBS assessed as induction of bacterial membrane depolarization at 2 to 32 ug/ml by flow cytometry,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1327105,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95908,95908,,Active,5181393,[],CHEMBL1667123,Antibacterial activity against Staphylococcus aureus grown in MHB medium assessed as induction of bacterial membrane depolarization at 2 to 32 ug/ml by flow cytometry,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1327105,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95909,95909,,,5181397,[],CHEMBL1667124,Binding affinity to cell membrane of Staphylococcus aureus grown in MHB medium at 8 ug/ml by scintillation counting relative to control,B,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1327105,=,1,0,=,,FC,,,2.8,CHEMBL2364031,Bacteria,Cell membrane,2.0,,,FC,,,,2.8
95910,95910,,Not Active,5181398,[],CHEMBL1667125,Antibacterial activity against Staphylococcus aureus assessed as induction of bacterial cell lysis at 8 to 32 ug/ml by spectrophotometry,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1327105,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95911,95911,,,5181400,[],CHEMBL1667581,Antibacterial activity against Staphylococcus aureus assessed as bacterial count at 8 to 32 ug/ml by turbidity assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1327105,=,1,0,=,,log10CFU/ml,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10CFU/ml,,,,3.0
95912,95912,,Not Active,5181401,[],CHEMBL1667582,Antibacterial activity against Staphylococcus aureus assessed as change in cellular membrane integrity at 8 to 32 ug/ml up to 6 hrs by spectrophotometry,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1649547,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1327105,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
95913,95913,,,5214294,[],CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,4.0
95914,95914,,,5214300,[],CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC50,ug ml-1,UO_0000274,,4.0
95915,95915,,,5214306,[],CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95916,95916,,,5214312,[],CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
95917,95917,,,5214318,[],CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC50,ug ml-1,UO_0000274,,2.0
95918,95918,,,5214324,[],CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95919,95919,,,5214330,[],CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC50,ug ml-1,UO_0000274,,0.25
95920,95920,,,5214336,[],CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95921,95921,,,5214342,[],CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95922,95922,,,5214348,[],CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95923,95923,,,5214354,[],CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95924,95924,,,5214360,[],CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95925,95925,,,5214366,[],CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95926,95926,,,5214372,[],CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95927,95927,,,5214378,[],CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95928,95928,,,5214384,[],CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95929,95929,,,5214390,[],CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95930,95930,,,5214396,[],CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95931,95931,,,5214402,[],CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95932,95932,,,5214408,[],CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95933,95933,,,5214414,[],CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95934,95934,,,5214420,[],CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95935,95935,,,5214426,[],CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95936,95936,,,5214432,[],CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95937,95937,,,5214438,[],CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC50,ug ml-1,UO_0000274,,0.12
95938,95938,,,5215479,[],CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC50,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.12
95939,95939,,,5215511,[],CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
95940,95940,,,5215517,[],CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC90,ug ml-1,UO_0000274,,8.0
95941,95941,,,5215523,[],CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95942,95942,,,5215529,[],CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
95943,95943,,,5215535,[],CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC90,ug ml-1,UO_0000274,,2.0
95944,95944,,,5215541,[],CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95945,95945,,,5215547,[],CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95946,95946,,,5215553,[],CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC90,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.12
95947,95947,,,5215559,[],CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95948,95948,,,5215565,[],CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95949,95949,,,5215571,[],CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95950,95950,,,5215577,[],CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95951,95951,,,5215583,[],CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95952,95952,,,5215589,[],CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95953,95953,,,5215595,[],CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95954,95954,,,5215601,[],CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95955,95955,,,5215607,[],CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95956,95956,,,5215613,[],CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95957,95957,,,5215619,[],CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95958,95958,,,5215625,[],CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95959,95959,,,5215631,[],CHEMBL1679372,Antibacterial activity against Clostridium sordellii by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95960,95960,,,5215637,[],CHEMBL1679373,Antibacterial activity against Clostridium spiroforme by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95961,95961,,,5215643,[],CHEMBL1679374,Antibacterial activity against Clostridium sporogenes by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614969,Clostridium sporogenes,Clostridium sporogenes,1509.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95962,95962,,,5215649,[],CHEMBL1679375,Antibacterial activity against Clostridium sporosphaeroides by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95963,95963,,,5215655,[],CHEMBL1679376,Antibacterial activity against Clostridium tertium by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC90,ug ml-1,UO_0000274,,0.25
95964,95964,,,5215661,[],CHEMBL1679377,Antibacterial activity against Clostridium sp. by CLSI M11-A6 agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.25
95965,95965,,,5215693,[],CHEMBL1679195,Antibacterial activity against Clostridium bolteae by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
95966,95966,,,5215699,[],CHEMBL1679196,Antibacterial activity against Clostridium clostridioforme by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614760,Enterocloster clostridioformis,Enterocloster clostridioformis,1531.0,,,MIC,ug ml-1,UO_0000274,,0.5
95967,95967,,,5215705,[],CHEMBL1679197,Antibacterial activity against Clostridium difficile by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,0.12
95968,95968,,,5215711,[],CHEMBL1679198,Antibacterial activity against Clostridium hathewayi by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.25
95969,95969,,,5215717,[],CHEMBL1679199,Antibacterial activity against Clostridium innocuum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614761,[Clostridium] innocuum,[Clostridium] innocuum,1522.0,,,MIC,ug ml-1,UO_0000274,,1.0
95970,95970,,,5215723,[],CHEMBL1679200,Antibacterial activity against Clostridium perfringens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.12
95971,95971,,,5215729,[],CHEMBL1679358,Antibacterial activity against Clostridium ramosum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC,ug ml-1,UO_0000274,,0.25
95972,95972,,,5215735,[],CHEMBL1679359,Antibacterial activity against Clostridium subterminale by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95973,95973,,,5215741,[],CHEMBL1679360,Antibacterial activity against Clostridium bartlettii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95974,95974,,,5215747,[],CHEMBL1679361,Antibacterial activity against Clostridium beijerinckii by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL5209646,Clostridium beijerinckii,Clostridium beijerinckii,1520.0,,,MIC,ug ml-1,UO_0000274,,0.12
95975,95975,,,5215753,[],CHEMBL1679362,Antibacterial activity against Clostridium bifermentans by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC,ug ml-1,UO_0000274,,0.12
95976,95976,,,5215759,[],CHEMBL1679363,Antibacterial activity against Clostridium butyricum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614964,Clostridium butyricum,Clostridium butyricum,1492.0,,,MIC,ug ml-1,UO_0000274,,0.12
95977,95977,,,5215765,[],CHEMBL1679364,Antibacterial activity against Clostridium celerecrescens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95978,95978,,,5215771,[],CHEMBL1679365,Antibacterial activity against Clostridium disporicum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95979,95979,,,5215777,[],CHEMBL1679366,Antibacterial activity against Clostridium glycolicum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95980,95980,,,5215783,[],CHEMBL1679367,Antibacterial activity against Clostridium hypermegas by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95981,95981,,,5215789,[],CHEMBL1679368,Antibacterial activity against Clostridium leptum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95982,95982,,,5215795,[],CHEMBL1679369,Antibacterial activity against Clostridium orbiscindens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95983,95983,,,5215801,[],CHEMBL1679370,Antibacterial activity against Clostridium paraputrificum by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,,MIC,ug ml-1,UO_0000274,,0.12
95984,95984,,,5215807,[],CHEMBL1679371,Antibacterial activity against Clostridium scindens by CLSI M11-A6 agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671662,Antimicrob Agents Chemother,2009.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331993,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
95985,95985,,,5215860,[],CHEMBL1677556,"Antimicrobial activity against streptomycin-resistant, vancomycin-susceptible Enterococcus faecalis BM4110 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
95986,95986,,,5215861,[],CHEMBL1677557,Antimicrobial activity against Enterococcus faecalis BM4110 expressing VanA and harboring transposon tn1546 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
95987,95987,,,5215862,[],CHEMBL1677558,Antimicrobial activity against Enterococcus faecium ATCC 51559 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
95988,95988,,,5215863,[],CHEMBL1677559,Antimicrobial activity against Enterococcus faecalis ATCC 51299 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
95989,95989,,,5215864,[],CHEMBL1677560,Antimicrobial activity against Enterococcus faecalis ATCC 51575 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332181,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
95990,95990,,Not Determined,5215880,[],CHEMBL1677420,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 assessed as UDP-MurNAc-tetrapeptide profile at 0.1 ug/ml by Western blotting,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1332181,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
95991,95991,,,5215881,[],CHEMBL1677422,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 harboring Van A gene assessed as UDP-MurNAc-tetrapeptide profile at 4 ug/ml by Western blotting,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,,Activity,%,,26.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,26.0
95992,95992,,,5215882,[],CHEMBL1677424,Induction of VanA activity in Enterococcus faecium ATCC 51559 expressing Van A gene assessed as UDP-MurNAc-tetrapeptide profile at 4 ug/ml by Western blotting,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,,Activity,%,,40.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,40.0
95993,95993,,Not Determined,5215883,[],CHEMBL1677426,Induction of VanA activity in Enterococcus faecalis ATCC 51299 expressing Van B gene assessed as UDP-MurNAc-tetrapeptide profile at 0.1 ug/ml by Western blotting,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1332181,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
95994,95994,,Not Determined,5215884,[],CHEMBL1677428,Induction of VanA activity in Enterococcus faecalis ATCC 51575 expressing Van B gene assessed as UDP-MurNAc-tetrapeptide profile at 0.1 ug/ml by Western blotting,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1332181,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
95995,95995,,,5215885,[],CHEMBL1677430,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 assessed as UDP-MurNAc-pentapeptide profile at 0.1 ug/ml by Western blotting,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
95996,95996,,Not Determined,5215886,[],CHEMBL1677432,Induction of VanA activity in vancomycin susceptible Enterococcus faecalis BM4110 harboring Van A gene assessed as UDP-MurNAc-pentapeptide profile at 4 ug/ml by Western blotting,F,,,BAO_0000375,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,,1332181,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
95997,95997,,,5215887,[],CHEMBL1677434,Induction of VanA activity in Enterococcus faecium ATCC 51559 expressing Van A gene assessed as UDP-MurNAc-pentapeptide profile at 4 ug/ml by Western blotting,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,,Activity,%,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,8.0
95998,95998,,,5215888,[],CHEMBL1677436,Induction of VanA activity in Enterococcus faecalis ATCC 51299 expressing Van B gene assessed as UDP-MurNAc-pentapeptide profile at 0.1 ug/ml by Western blotting,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
95999,95999,,,5215889,[],CHEMBL1677438,Induction of VanA activity in Enterococcus faecalis ATCC 51575 expressing Van B gene assessed as UDP-MurNAc-pentapeptide profile at 0.1 ug/ml by Western blotting,F,,,BAO_0001103,BAO_0000218,organism-based format,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@H](Oc3c4cc5cc3Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]5C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c5cc(O)c(CNCP(=O)(O)O)c(O)c5-c5cc3ccc5O)[C@H](O)c3ccc(c(Cl)c3)O4)O[C@H](CO)[C@@H](O)[C@@H]2O)O[C@@H](C)[C@H]1O,,,CHEMBL1671695,Antimicrob Agents Chemother,2010.0,,CHEMBL507870,TELAVANCIN,CHEMBL507870,,0,http://qudt.org/vocab/unit#Percent,1332181,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
